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A B S T R A C T
Background
Children with developmental speech sound disorders have difficulties in producing the speech sounds of their native language. These
speech difficulties could be due to structural, sensory or neurophysiological causes (e.g. hearing impairment), but more often the cause of
the problem is unknown. One treatment approach used by speech-language therapists/pathologists is non-speech oral motor treatment
(NSOMT). NSOMTs are non-speech activities that aim to stimulate or improve speech production and treat specific speech errors.
For example, using exercises such as smiling, pursing, blowing into horns, blowing bubbles, and lip massage to target lip mobility for
the production of speech sounds involving the lips, such as /p/, /b/, and /m/. The efficacy of this treatment approach is controversial,
and evidence regarding the efficacy of NSOMTs needs to be examined.
Objectives
To assess the efficacy of non-speech oral motor treatment (NSOMT) in treating children with developmental speech sound disorders
who have speech errors.
Search methods
InApril 2014we searched theCochraneCentral Register of ControlledTrials (CENTRAL),OvidMEDLINE (R) andOvidMEDLINE
In-Process & Other Non-Indexed Citations, EMBASE, Education Resources Information Center (ERIC), PsycINFO and 11 other
databases. We also searched five trial and research registers, checked the reference lists of relevant titles identified by the search and
contacted researchers to identify other possible published and unpublished studies.
Selection criteria
Randomised and quasi-randomised controlled trials that compared (1) NSOMT versus placebo or control; and (2) NSOMT as
adjunctive treatment or speech intervention versus speech intervention alone, for children aged three to 16 years with developmental
speech sound disorders, as judged by a speech and language therapist. Individuals with an intellectual disability (e.g. Down syndrome)
or a physical disability were not excluded.
Data collection and analysis
The Trials Search Co-ordinator of the Cochrane Developmental, Psychosocial and Learning Problems Group and one review author
ran the searches. Two review authors independently screened titles and abstracts to eliminate irrelevant studies, extracted data from
the included studies and assessed risk of bias in each of these studies. In cases of ambiguity or information missing from the paper, we
contacted trial authors.
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Main results
This review identified three studies (from four reports) involving a total of 22 children that investigated the efficacy of NSOMT
as adjunctive treatment to conventional speech intervention versus conventional speech intervention for children with speech sound
disorders. One study, a randomised controlled trial (RCT), included four boys aged seven years one month to nine years six months
- all had speech sound disorders, and two had additional conditions (one was diagnosed as “communication impaired” and the other
as “multiply disabled”). Of the two quasi-randomised controlled trials, one included 10 children (six boys and four girls), aged five
years eight months to six years nine months, with speech sound disorders as a result of tongue thrust, and the other study included
eight children (four boys and four girls), aged three to six years, with moderate to severe articulation disorder only. Two studies did
not find NSOMT as adjunctive treatment to be more effective than conventional speech intervention alone, as both intervention and
control groups made similar improvements in articulation after receiving treatments. One study reported a change in postintervention
articulation test results but used an inappropriate statistical test and did not report the results clearly. None of the included studies
examined the effects of NSOMTs on any other primary outcomes, such as speech intelligibility, speech physiology and adverse effects,
or on any of the secondary outcomes such as listener acceptability.
The RCT was judged at low risk for selection bias. The two quasi-randomised trials used randomisation but did not report the method
for generating the random sequence and were judged as having unclear risk of selection bias. The three included studies were deemed
to have high risk of performance bias as, given the nature of the intervention, blinding of participants was not possible. Only one study
implemented blinding of outcome assessment and was at low risk for detection bias. One study showed high risk of other bias as the
baseline characteristics of participants seemed to be unequal. The sample size of each of the included studies was very small, which
means it is highly likely that participants in these studies were not representative of its target population. In the light of these serious
limitations in methodology, the overall quality of the evidence provided by the included trials is judged to be low. Therefore, further
research is very likely to have an important impact on our confidence in the estimate of treatment effect and is likely to change the
estimate.
Authors’ conclusions
The three included studies were small in scale and had a number of serious methodological limitations. In addition, they covered
limited types of NSOMTs for treating children with speech sound disorders of unknown origin with the sounds /s/ and /z/. Hence, we
judged the overall applicability of the evidence as limited and incomplete. Results of this review are consistent with those of previous
reviews: Currently no strong evidence suggests that NSOMTs are an effective treatment or an effective adjunctive treatment for children
with developmental speech sound disorders. Lack of strong evidence regarding the treatment efficacy of NSOMTs has implications for
clinicians when they make decisions in relation to treatment plans. Well-designed research is needed to carefully investigate NSOMT
as a type of treatment for children with speech sound disorders.
P L A I N L A N G U A G E S U M M A R Y
Non-speech oral motor treatment for children with developmental speech sound disorders
Review question
We reviewed the evidence on the effects of non-speech oral motor treatment (NSOMT) for treating children with developmental
speech sound disorders who have speech errors.
Background
Children with developmental speech sound disorders have difficulties in producing the speech sounds of their own language. These
speech difficulties could be due to structural, sensory or neurophysiological causes (e.g. hearing impairment), but more often the cause
of the problem is unknown. One treatment approach used by speech and language therapists or pathologists consists of non-speech
oral motor treatments (NSOMTs). NSOMTs are activities that aim to stimulate or improve speech production and treat children with
specific speech errors without requiring that the child produce a speech sound. This method of therapy uses exercises, such as smiling,
pursing, blowing into horns and blowing bubbles and performing lip massage to target lip mobility for the production of speech sounds
involving the lips, such as /p/, /b/ and /m/. Whether NSOMTs are effective for treating children with speech errors is controversial.
Therefore, evidence regarding the effects of NSOMTs must be examined.
Study characteristics
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The evidence is current to April 2014. We found three studies (from four reports) involving a total of 22 children aged three to nine years
who received a combination of NSOMTs and articulation or phonological therapy (intervention group), or articulation or phonological
therapy alone (control group). One study was a randomised controlled trial in which four boys with speech sound disorders were
randomly assigned to one of the two groups. In this study, each participant received 16 × 30-minute individual therapy sessions, twice
per week over eight weeks, to treat the speech sound ’s’. For the intervention group, NSOMT (oral placement therapy) was conducted
in the first 10 minutes of each session, followed by 20-minute articulation therapy. The other two studies used randomisation, but the
method used to generate the random sequence was not reported. In these studies, six boys and four girls, all with speech sound disorders
due to tongue thrust, were randomly assigned to one of the two groups. Each participant received 22 × 30-minute individual sessions
conducted weekly in the first six weeks, and twice a week in the following eight weeks, to treat ’s’ and ’z’ sounds. The intervention
group received NSOMT (Hanson’s 1977 approach) in the first six weeks and alternating sessions of NSOMT and articulation therapy
in the following eight weeks. The final study randomly assigned four boys and four girls with moderate to severe articulation disorder
alone to either intervention group or control group. Each participant received 9 × 20-minute group therapy sessions (two participants
in each group), conducted twice a week over five weeks. For the intervention group, NSOMT (oral motor exercises for speech clarity)
was conducted during the first 10 minutes of each session. Speech errors associated with the ’s’ sound were treated for the intervention
group; however, the speech sound(s) treated for the control group were not detailed. None of the studies reported funding support.
Key results
Two studies (one that used oral placement therapy and one that used Hanson’s 1977 approach) did not find NSOMT as an adjunctive
treatment to be more effective than conventional speech intervention only, as both intervention and control groups had made similar
improvements in articulation after treatment (i.e. fewer speech errors or increased percentage of correct articulation). The study that
used oral motor exercises for speech clarity as the NSOMT reported a change in articulation test results after treatment, but used an
inappropriate statistical test and did not report the results clearly.
Quality of the evidence
The three included studies were small in scale and had a number of serious methodological limitations. Moreover, these studies
covered limited types of NSOMTs for treating just one class of speech sounds - ’s’ with or without ’z’ - in children with speech sound
disorders. Hence, the overall applicability of the evidence is limited, and the evidence is believed to be incomplete and of low quality.
To conclude, currently no strong evidence indicates whether NSOMTs are effective as treatment or adjunctive treatment for children
with developmental speech sound disorders.
B A C K G R O U N D
Description of the condition
’Developmental speech sound disorders’ is a generic term that
refers to “any combination of difficulties with perception, artic-
ulation/motor production, and/or phonological representation of
speech segments (consonants and vowels), phonotactics (syllable
and word shapes), and prosody (lexical and grammatical tones,
rhythm, stress, and intonation) that may impact speech intelligi-
bility and acceptability” in children (IEPMCS 2012, p 1). These
speech difficulties can reflect a secondary impact of a structural
deficit of the articulators (e.g. cleft palate), a sensory or motor
disorder (e.g. hearing impairment) or a neuromuscular disorder
(e.g. dysarthria, apraxia of speech). Alternatively, they may indi-
cate a primary disorder for which the cause is unknown (Flipsen
2009; IEPMCS 2012; Ruscello 2008a; Shriberg 2010). Speech
sound disorders can have damaging effects on many aspects of
life. Speech problems can hamper daily communication, causing
difficulties in socialisation. It has been reported that some forms
of speech sound disorders are associated with difficulties in read-
ing, writing, spelling and mathematics, and it has been estimated
that about 50% to 70% of children with speech sound disorders
show general academic difficulty throughout secondary education
(seeWilliams 2010). Academic difficultiesmay affect employment
later in adulthood. Thus, the impact of speech sound disorders
can be manifold and long-lasting for the affected individual.
Speech sound disorders are common in children. It has been esti-
mated that around 7.5% of children between three and 11 years of
age have clinically significant speech difficulties (Shriberg 1994).
Children with developmental speech sound disorders account for
a large proportion of the caseloads of speech and language thera-
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pists (SLTs) - nearly half of a typical caseload for clinicians in the
UK and Australia (see Joffe 2008). In the US, it has been esti-
mated that about 80% of children with speech sound disorders
require treatment services and about 92% of school-based speech-
language pathologists provide treatment services to children with
speech sound disorders (see Ruscello 2008a).
Description of the intervention
Phonetic and phonemic treatments
Different treatment approaches for managing speech sound dis-
orders have been developed; they can be categorised broadly into
phonetic (or sensory motor-based) treatments, phonemic (or con-
ceptual-based) treatments and hybrid treatments that incorporate
both phonetic and phonemic components (Ruscello 2008b). Pho-
netic treatments focus on improving the accuracy of articulatory
movements for speech sounds through different levels of prac-
tice, from an isolated sound level to attain correct target sound
production, to nonsense syllables, words, phrases and finally con-
versational speech (Ruscello 2008a; Ruscello 2008b). For phone-
mic treatments, the aim is to restructure or develop the child’s
phonological knowledge through different types of contrastive
practice (e.g. minimal pairs) or metalinguistic awareness tasks (e.g.
metaphon), or both (Ruscello 2008a; Ruscello 2008b). Hybrid
treatments consist of a combination of phonetic and phonemic
treatments in which both phonetic practice and phonemic con-
trast are employed (Ruscello 2008a).
Clinical decisions about which treatment approach should be
adopted for a particular child are based mainly on the cause of the
speech disorder. For example, phonetic approaches, which focus
on developing the child’s motor skills, are usually applied for those
who have knowledge of phonological rules of the language but are
unable to produce certain speech sounds correctly. Speech therapy
using phonetic, phonemic or a combination of these approaches
is regarded as standard speech intervention.
Non-speech oral motor exercises
One alternate or adjunctive (i.e. additional to a phonetic or phone-
mic approach) approach for managing developmental speech
sound disorder consists of non-speech oral motor treatments
(NSOMTs). An operational definition of NSOMTs is provided
by the National Center for Evidence-Based Practice in Communi-
cation Disorders of the American Speech-Language-Hearing As-
sociation (ASHA), which defines NSOMTs as “non-speech activ-
ities that involve sensory stimulation to or actions of the lips, jaw,
tongue, soft palate, larynx, and respiratory muscles that are in-
tended to influence the physiological underpinnings of the oropha-
ryngeal mechanism to improve its function. They may include
activities described as active muscle exercise, muscle stretching,
passive exercise, or sensory stimulation” (McCauley 2009, p 344).
NSOMTs are different from phonetic and phonemic treatments
in that they do not involve the practice of speech sound articula-
tion and auditory discrimination of the error sound and the tar-
get sound. Instead, they target non-speech sensory or motor func-
tion, or both, and postures of articulators, with the aim of devel-
oping motor skills for correct speech sound production (Ruscello
2008a). For example, motor skills developed by exercising the
lips in non-speech activities, such as blowing horns, straws and
bubbles, are thought to generalise to those required for produc-
tion of bilabial speech sounds /p/, /b/ and /m/ (Marshalla 2000;
Rosenfeld-Johnson 2001). The paper by Ruscello 2008b provides
a detailed overview of various types of NSOMTs.
NSOMTs are used in a variety of ways and for different client
groups. A survey conducted in theUS revealed that most clinicians
- 68%of 537 respondents - usedNSOMTs as an adjunctive ’warm-
up’ technique followed by speech intervention (Lof 2008). About
25% of clinicians used NSOMTs in conjunction with speech in-
tervention and 7% used NSOMTs exclusively to target speech
production (Lof 2008). The survey also showed that clinicians of-
ten used NSOMTs with children who present with motor speech
disorders, structural anomalies (e.g. cleft palate) or Down syn-
drome (Lof 2008). They used NSOMTs, albeit less frequently,
with children identified as late talkers and those with phonological
disorders, hearing impairment and speech sound disorders of un-
known origin (Lof 2008). A survey conducted in Canada reported
slightly different findings. There, clinicians are most likely to use
NSOMTswith children exhibiting phonological disorders, apraxia
of speech, dysarthria, Down syndrome or cerebral palsy (Hodge
2005b). In the UK, an unexpected finding was that NSOMTs are
used more often by inexperienced therapists (one to three years)
than by very experienced therapists (over 10 years) (Joffe 2008).
How the intervention might work
The use of NSOMTs for treating children with speech sound dis-
orders is motivated by several assumptions (for details, see, for
example, Bunton 2008; Clark 2010; and Ruscello 2008b). One
assumption is that there is a common set of motor control princi-
ples and neural anatomical representation in the human nervous
system for speech and non-speech activities that involve the same
structures. Hence, for example, movement characteristics and task
demands for the production of bilabial speech sounds and those
for blowing bubbles or horns are presumably similar, and the train-
ing effect caused by practising blowing bubbles or horns could
be transferred to the production of bilabial sounds. Another as-
sumption is based on the principles of motor learning, which sug-
gest that learning could be facilitated by breaking down complex
movements into subcomponents because this allows “the motor
system to plan simpler movement patterns and gradually develop
skilled control of more complex movement patterns” (Clark 2010,
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p 586). Hence, for example, to treat a child with a speech error
for the sound /s/, exercises for establishing jaw stability, tongue
stability, elevation of the lateral sides of the tongue, elevation of
the tip of the tongue and so on are used (Marshalla 2000).
Why it is important to do this review
An abundance of commercial products and training workshops
are available for NSOMTs; many clinicians use this approach for
treating children with developmental speech sound disorders. For
example, a survey conducted in the US in 2008 found that 85%
of respondents reported using NSOMTs in their clinical prac-
tice (Lof 2008). However, use of this treatment approach in the
US seems to be declining, as a recent survey reported that only
67%of respondents usedNSOMTswith their clients (Brumbaugh
2013). (Similar surveys have been conducted in other countries;
see Hodge 2005b; Joffe 2008; McLeod 2014.) Nevertheless, the
use of NSOMTs for treating children with speech sound disor-
ders is controversial. A number of research papers, book chap-
ters and journal articles have discussed the theoretical reasons why
NSOMTs might not be effective. See, for example, the clinical fo-
rum on NSOMTs published in the journal, Language, Speech, and
Hearing Services in Schools (2008, volume 39, issue 3); a special
issue, ’Controversies surrounding nonspeech oral motor exercises
for childhood speech disorders’, published in the journal Seminars
in Speech and Language (2008, volume 29, issue 4); and other arti-
cles (e.g. Bowen 2005; Lof 2009; Lof 2010). Lof andWatson (Lof
2010) summarised the arguments about why NSOMTs do not
work. First, isolated training of individual speech movements will
not generalise to the whole articulatory gesture. Second,NSOMTs
are not useful for improving muscle strength because it has been
shown that high muscular strength is not required for producing
speech. Moreover, reduced speech intelligibility and speech sound
errors are not caused by reduced muscular strength of the articula-
tors. Third, previous studies have demonstrated that neural organ-
isation for speech and non-speech tasks is different, even though
the same oral structures are involved in those speech and non-
speech tasks. Fourth, NSOMTs for the purpose of warming up
muscles or increasing children’s awareness of their articulators are
not useful or necessary because speaking does not tax themuscular
system.
Although several research papers have discussed or reviewed the ef-
ficacy of NSOMTs (Forrest 2002; Lass 2008; Lof 2003;McCauley
2009; Ruscello 2008b; Ruscello 2008c; Ruscello 2010), the re-
views were not conducted according to the standards set by The
Cochrane Collaboration - the types of studies reviewed were not
limited to randomised clinical trials (RCTs) and quasi-RCTs; only
studies published in English were included for review; and the
literature search was limited to databases that encompassed peer-
reviewed journals. Cochrane systematic reviews have examined
the efficacy of speech intervention for speech problems related
to childhood apraxia of speech (Morgan 2008a), dysarthria asso-
ciated with acquired brain injury (Morgan 2008b) and primary
speech and language delay or disorder (Law 2003). These reviews
comparedNSOMTs versus standard speech intervention and eval-
uated treatment efficacy for three levels of outcomes. However,
it is uncertain whether factors such as frequency of therapy ses-
sions and presence or absence of intellectual disability could af-
fect the treatment efficacy of NSOMTs. Although some overlap
may be seen with these systematic reviews, this review will cover a
broader spectrum of developmental conditions and consequently
will provide a more detailed evaluation of the treatment efficacy
of NSOMTs.
Given the high incidence of speech sound disorders and the abun-
dance of commercial products and training workshops developed
for use with NSOMTs (Kamhi 2008), evidence regarding the ef-
ficacy of NSOMTs must be examined, so that clinicians can make
informed decisions to ensure evidence-based practice in their treat-
ment plans. Moreover, patients and their families need to be made
aware of the evidence related to efficacy, or lack thereof, for treat-
ments that involve NSOMTs.
O B J E C T I V E S
To assess the efficacy of non-speech oral motor treatment
(NSOMT) in treating children with developmental speech sound
disorders who have speech errors.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All relevant randomised and quasi-randomised controlled trials
(e.g. studies in which participants were allocated to treatment by
alternate allocation or allocation by date of birth). We excluded
trials using a cross-over design. This research design generally is
not suitable for interventions that cause a permanent change in
behaviour (e.g. reduced speech errors, improved articulation after
speech intervention), as the effect of one treatment may carry over
and alter the response to subsequent treatment (Sibbald 1998).
Types of participants
Children aged three to 16 years with developmental speech sound
disorders, as judged by a speech-language therapist. We did not
exclude individuals with an intellectual disability (e.g. Down syn-
drome) or a physical disability.
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Types of interventions
Non-speech oral motor treatment (NSOMT) versus treatment
with placebo or control; and NSOMT as adjunctive treatment,
for example, speech intervention with NSOMT compared with
speech intervention alone. We placed no restriction on the fre-
quency, intensity or duration of the intervention.
Types of outcome measures
Primary outcomes
Although NSOMTs target non-speech behaviours, this treatment
approach is assumed to have a positive effect on speech. Hence,
we included the following speech primary outcomes.
• Correct articulation of speech sounds targeted by the
treatment as measured by standardised tests (e.g. Goldman-
Fristoe Test of Articulation Second Edition (GFTA-2) (Goldman
2000)) or non-standardised articulation tests (e.g. percentage of
correct speech sounds produced as determined by perceptual
evaluation of articulation).
• Speech intelligibility measured using a perceptual rating
scale or percentage of words transcribed correctly by the
investigator.
• Speech physiology as measured by instrumental techniques
such as acoustic analysis (e.g. measure of format frequencies for
assessing vowel production), kinematic analysis and articulatory
placement.
• Adverse effect of an increase in articulation errors after
treatment, which could be measured by the standardised and
non-standardised tests listed above. These articulation tests
should be conducted by a speech-language therapist (SLT).
We planned to include all primary outcomes in a ’Summary of
findings’ table.
Secondary outcomes
• Listener acceptability, speech naturalness or bizarreness (e.g.
as judged by a naive listener using a perceptual rating).
• Self perception of change in articulation or speech
intelligibility (e.g. as measured using a rating scale).
Time points for measuring outcomes
• Immediately (within one month) after cessation of the
intervention.
• One to 12 months after cessation of the intervention.
• One to two years after cessation of the intervention.
Search methods for identification of studies
The Trials Search Co-ordinator for the Cochrane Developmental,
Psychosocial and Learning ProblemsGroup and one review author
(AL) ran the searches in August 2012. The searches were updated
in February 2013 and again in April 2014.
Electronic searches
We searched the following databases.
• Cochrane Central Register of Controlled Trials
(CENTRAL) (2014 Issue 3).
• Ovid MEDLINE (R), 1946 to April Week 1 2014.
• Ovid MEDLINE In-Process & Other Non-index
Citations, 14 April 2014.
• EMBASE (Ovid), 1980 to Week 15 2014.
• Education Resources Information Center (ERIC)
(ProQuest), 1966 to current.
• PsyINFO (Ovid), 1806 to April Week 2 2014.
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL) (EBSCOhost), 1939 to current.
• Science Citation Index-Expanded (SCI-EXPANDED)
(Web of Knowledge), 1970 to 11 April 2014.
• Social Science Citation Index (SSCI) (Web of Knowledge),
1970 to 11 April 2014.
• Conference Proceedings Citation Index-Sciences (CPCI-S);
Conference Proceedings Citation Index-Social Sciences &
Humanities (CPCI-SSH), 1990 to 11 April 2014.
• Latin American Caribbean Health Sciences Literature
(LILACS), all available years.
• Academic Search Complete (EBSCOhost), all available
years.
• ProQuest Dissertations and Theses: UK & Ireland, 1990 to
current.
• ProQuest Dissertations and Theses, Abstracts International
(AI), 1970 to current.
• Cochrane Database of Systematic Reviews (CDSR) (2014
Issue 4).
• Database of Abstracts of Reviews of Effects (DARE) (2014
Issue 1).
• speechBITE, www.speechbite.com/: all available years.
We also searched the following trials registers.
• National Research Register Archive (last modified 27
October 2010 ) (nihr.ac.uk/Pages/NRRArchive.aspx).
• UK Clinical Research Network (UKCRN) Portfolio
Database (public.ukcrn.org.uk/search/).
• ClinicalTrials.gov (clinicaltrials.gov/).
• metaRegister of Controlled Trials (mRCT) (controlled-
trials.com).
• World Health Organization International Clinical Trials
Registry Platform (ICTRP) (apps.who.int/trialsearch/
default.aspx).
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We applied no restrictions to language, date or status of publica-
tion. We planned to seek translation when necessary; however, all
included studies were written in English, so translation was not
needed. The search strategies are detailed in Appendix 1.
Searching other resources
We checked the reference lists of relevant journal papers, book
chapters and systematic reviews identified by the electronic
searches. We emailed colleagues and researchers to identify other
published and unpublished studies for possible inclusion such as
technical or research reports, conference papers and dissertations.
Data collection and analysis
Selection of studies
We managed all references generated by the search strategy using
Endnote (Endnote). We eliminated duplicates. Two review au-
thors (AL and FG) independently conducted an initial screening
of titles and abstracts to exclude references that did not meet the
inclusion criteria. We obtained full papers for those that provided
insufficient information in the abstract. These two review authors
independently evaluated the papers and resolved disagreements by
discussion.
Data extraction and management
A data extraction form was developed and piloted before data ex-
traction was carried out. Two review authors (AL and FG) inde-
pendently extracted the following information from each paper.
• Participants: number, age, sex, inclusion and exclusion
criteria, severity level of developmental speech sound disorders
and other baseline characteristics reported (e.g. hearing ability,
intellectual disability).
• Methods: speech assessment(s), outcome measure(s) used
and assessment results (e.g. numbers and types of articulation
errors).
• Interventions: types of interventions, number of therapy
sessions given, duration of each therapy session, frequency of
therapy and length of intervention, date and location and
whether compliance was evaluated.
• Intervention integrity: Using the coding categories
proposed by Dane and Schneider (Dane 1998), we recorded, for
example, whether a training manual outlining the intervention
procedures was available to intervention provider(s), and
whether the intervention provider(s) was given specific training
regarding implementation of intervention procedures.
Assessment of risk of bias in included studies
Two review authors (AL and FG) independently assessed risk of
bias in each included study across the following six domains ac-
cording to the Cochrane Handbook for Systematic Reviews of Inter-
ventions (Higgins 2011). This assessment consisted of two parts:
(1) a succinct description, which included verbatim quotes from
the paper or correspondence with the trial author(s), a comment
from the review author about procedures used to avoid bias, or
both; and (2) an assessment of risk of bias (resulting in assignment
of a judgement of ‘low risk’, ‘high risk’ or ‘unclear risk’ of bias) for
each of the domains described below. Studies that were judged as
‘high risk’ for each area of potential risk of bias were not included
in subsequent analyses.
Sequence generation
Review authors described the method used to generate the alloca-
tion sequence using quotes when possible. They added a comment
such as ‘probably done’ or ‘probably not done’ to supplement any
ambiguous quote and assigned each included study to one of the
following categories.
• ‘Low risk’ - adequate method used for randomisation (e.g.
computer generated, table of random numbers) or quasi-
randomisation.
• ‘High risk’ - inadequate method of randomisation used (e.g.
case file number, date of birth, alternate numbers).
• ‘Unclear risk’ - uncertainty about whether an appropriate
method of randomisation was used.
Allocation concealment
As regards the method used to conceal the allocation sequence, we
assigned each included study to one of the following categories.
• ‘Low risk’ - adequate concealment of allocation (e.g. pre-
numbered or coded identical containers administered serially to
participants).
• ‘High risk’ - allocation not adequately concealed (e.g.
alternate assignment).
• ‘Unclear risk’ - uncertainty about whether allocation was
adequately concealed (e.g. study authors did not describe
allocation methods).
Blinding
Blinding of participants and intervention providers (i.e. the SLTs)
was not possible, but blinding of outcome assessor(s) and data
analyst(s) from knowledge of which intervention a participant had
received should have been ensured. Review authors evaluated and
graded the method used to ensure blinding as ‘low risk’, ‘high
risk’ or ‘unclear risk’ of bias. We performed assessment for each
main outcome (e.g. outcome measured at six months post therapy,
outcome measured at 12 months post therapy).
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Incomplete outcome data
’Incomplete outcome data’ refers to data that are missing as a
result of attrition (dropout) during the study or exclusion from
the analysis. We noted the numbers of, and reason(s) for, attrition
or exclusions, and whether attrition was analysed appropriately
(e.g. intention-to-treat (ITT) analysis). We graded this domain as
having ‘low risk’, ‘high risk’ or ‘unclear risk’ of bias according to
the criteria stated in theCochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011).
Selective reporting bias
This is also known as ’within-study publication bias’, which may
arise in several ways (Higgins 2011).
• Only some of the analysed outcomes were included in the
study.
• Outcomes were measured at different time points, or
different instruments or assessors were employed to measure
outcomes at the same time point.
• Selective reporting of analysis was performed using the
same data.
• Results of subscales of a full measurement scale or a subset
of events were selectively reported.
• Some outcomes were reported but with inadequate detail
for the data to be included in a meta-analysis.
We assigned each included study to one of the following quality
criteria.
• ‘Low risk’ indicating that studies have reported all
prespecified outcomes.
• ‘High risk’ indicating that any of the above-mentioned
selective reporting is evident in the study.
• ‘Unclear risk’ indicating that it is uncertain whether
selective reporting bias has been avoided.
Other sources of bias
Other sources of bias may include baseline imbalance, early stop-
ping and co-intervention. We described the nature of the bias and
graded this domain as having ‘low risk’, ‘high risk’ or ‘unclear risk’
of bias.
Measures of treatment effect
We did not carry out further quantitative analysis of the data, as
the three identified trials used different NSOMTs and outcome
measures (see the ’Interventions’ and ’Outcomes’ subsections in
the Results section below). Thus, methods planned in the protocol
(Lee 2011) were not used in this review but will be used in updates
of this review (see Table 1).
R E S U L T S
Description of studies
See Characteristics of included studies and Characteristics of
excluded studies.
Results of the search
The searches identified a total of 7691 records. After removing
duplicates, the two review authors (AL and FG) independently
screened the titles and abstracts of 5853 records and identified 24
potentially relevant articles. We retrieved and assessed the full-text
reports for eligibility and determined that four reports met the
inclusion criteria. See Figure 1 for the study flow diagram.
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Figure 1. Study flow diagram.
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One of the four reports is a conference paper (poster) authored by
Fields and Polmanteer, which reported the same results as Fields’
Master’s thesis (Fields 2003). Data from Fields’ study reported in
this review were taken from Fields 2003, as this report included
the full details of Fields’ study. Hence, this review identified three
relevant studies (from four reports) that investigated the efficacy
of NSOMTs as adjunctive treatment to conventional speech in-
tervention for children with speech sound disorders.
Included studies
The three included studies are Christensen 1981, Fields 2003
and Sargenti 2011. The study by Christensen and Hanson
(Christensen 1981) was published in a peer-reviewed journal. The
studies by Fields (Fields 2003) and by Sargenti (Sargenti 2011)
were undertaken and published as Master’s theses.
Location of studies
The three included studies were conducted in the United States -
Salt Lake City School District, Utah, for Christensen 1981; rural
eastern Kentucky for Fields 2003; and northern New Jersey for
Sargenti 2011.
Participants
The study by Christensen 1981 included 10 children (six boys and
four girls) aged between five years eight months and six years nine
months; the study by Fields 2003 included eight children (four
boys and four girls) aged between three and six years; and the study
by Sargenti 2011 included four boys aged between seven years one
month and nine years six months. Participants in all three stud-
ies were diagnosed as having speech sound disorders. In Chris-
tensen and Hanson’s study, the 10 participants showed “visually
and acoustically distorted /s/ and /z/, and two or more other den-
tally or interdentally produced tongue-tip sounds” (Christensen
1981, p 162). In Fields’ study, the eight participants had “mod-
erate-to-severe articulation disorder” (Fields 2003, p 12). Three
participants in the intervention group showed cluster reduction
for /s/ clusters, and one showed stridency deletion; these errors
were targeted in the NSOMTs. The study did not report other
speech errors noted among participants in the intervention group,
nor did it provide the details of speech errors demonstrated by
participants in the control group. In Sargenti’s study, the four par-
ticipants showed “distorted production of /s/ and /z/ phonemes”
and “an interdental (frontal) or lateral lisp” (Sargenti 2011, p 17).
This study did not report other speech errors that the participants
might have had or the severity level of these speech disorders.
Other participant baseline characteristics were slightly different
among the three studies. In Christensen 1981 and Sargenti 2011,
all participants had normal hearing, and participants in Sargenti’s
study also had delayed motor control (Sargenti 2011); however,
participants’ hearing ability and motor control ability were not re-
ported in Fields 2003. The expressive and receptive language abil-
ities of participants in all three studies were not fully tested; how-
ever, those in Fields 2003 were judged to be within normal limits
for their receptive vocabulary. Whereas in the study by Sargenti
2011, one participant in the intervention group was diagnosed
as “communication impaired” and one in the control group was
classified as “multiply disabled (communication impaired, Atten-
tion Deficit Hyperactivity Disorder, Tourette Syndrome, and Ob-
sessive-Compulsive Disorder)” (p 17). The other two participants
had “normal academic and language abilities” (p 17). For the
Christensen 1981 study, “some unusual individual characteristics”
were observed in four participants during the course of treatment
(p 164). One participant in the intervention group did not com-
plete the home practice because she was not compliant with it,
and another participant in this group “was found to have a visual
learning disability and had real difficulty using a mirror for tongue
thrust exercises (the NSOMT)” (p 164). One participant in the
control group showed “language disability involving syntax and
semantics as well as phonology”, and another participant in the
same group had an anterior overjet which “made correct /s/ pro-
duction difficult” (p 164).
Interventions
Christensen 1981 used “Hanson’s 1977 approach” (Barrett 1978)
to NSOMTs. Fields 2003 used “oral motor exercises for speech
clarity” developed by Rosenfeld-Johnson (Rosenfeld-Johnson
2001), and Sargenti 2011 used “oral placement therapy” (OPT)
for /s/ and /z/, which was also developed by Rosenfeld-Johnson
(Rosenfeld-Johnson 2009).
Christensen 1981 provided little information on the “Hanson’s
1977 approach”, stating only that this programme “included the
use of neuromuscular facilitation techniques” (p 162). Study au-
thors provided no information on the activities or exercises used
for treating target speech sounds.
Oral motor exercises for speech clarity (Rosenfeld-Johnson 2001)
include exercises for the jaw, lips and tongue. In the Fields’ study,
exercises used in the intervention were selected on the basis of the
oral motor weakness identified in individual participants and the
phoneme(s) that weremisarticulated (Fields 2003).Hence, tongue
exercises were administered to participants one and two; whereas
jaw exercises were given to participants three and four. Participant
one completed the four steps in the first exercise - “tongue-tip
lateralisation midline to either side” - and the first two steps (six
steps altogether) in the second exercise - “tongue-tip lateralisation
across midline”. Participant two completed the four steps of the
first tongue exercise and the first step of the second tongue exercise.
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Participants three and four completed the first two of the three
steps of the “Bite Block #2” exercise.
Oral placement therapy (OPT) for /s/ and /z/ (Rosenfeld-Johnson
2009) includes exercises for the jaw, lips and tongue, and use of the
following tools: Talk Tools Jaw Grading Bite Blocks, Talk Tools
Bubble Kit and Talk Tools Horn Kit, as well as a sensory pro-
gramme that uses Talk Tools Vibrator/Toothettes (oral swab). In
Sargenti 2011, exercises used in the intervention were selected on
the basis of individual participant results on the Initial Speech
System Evaluation (which comes with this treatment package).
Hence, participant one went through the following exercises dur-
ing the course of the intervention: bite block exercises level #2 to
#7, blow bubble exercises level #3 to #5 and blow horn exercises
level #2 to #12, whereas participant two went through bite block
exercises level #4 to #7 and blow horn exercises level #9 to #12.
Results of the Initial Speech System Evaluation revealed that both
participants had “hypo-sensitivity/responsivity” (p 22); thus, the
sensory programme was administered to participants at the start
of each therapy session “to increase awareness” before oral motor
therapywas provided (p 26). The programme startedwith rubbing
both sides of the buccal cavity, the upper and lower gum ridges,
the surface and lateral margins of the tongue and the hard palate
of the participant using a dampened Talk Tools Toothette; the
procedure was repeated using a Talk Tools Vibrator. The sensory
programme took about one to two minutes to complete.
In Christensen 1981, participants in both intervention and con-
trol groups initially received 1.5 to 2.5 30-minute sessions of con-
ventional articulation therapy targeting four sounds - /t/, /d/, /
l/ and /n/. After this, the intervention group received NSOMTs
and conventional articulation therapy, whereas the control group
received conventional articulation therapy only. In Fields 2003,
the intervention group received NSOMTs as well as conventional
articulation or phonological therapy, whereas the control group
received conventional articulation or phonological therapy only.
In Sargenti 2011, the intervention group received NSOMTs and
conventional articulation therapy, whereas the control group re-
ceived conventional articulation therapy only.
None of the included studies reported who delivered the interven-
tion. In addition, two studies (Christensen 1981; Sargenti 2011)
did not report whether investigators adhered to the intervention
plan. As stated below, although Fields 2003 planned to conduct
10 therapy sessions, one session was not implemented for personal
reasons of the trial author, who did not report whether investiga-
tors adhered to all other aspects of the intervention plan.
Duration and frequency of treatments
The frequency of treatment sessions was two sessions per week for
two studies (Fields 2003; Sargenti 2011). In Christensen 1981,
treatment was conducted once a week for the first six weeks and
twice a week for the following eight weeks. The total number
of treatment hours was different between the three studies - 11
hours for Christensen and Hanson’s study (22 × 30-minute ses-
sions), three hours for Fields’ study (10 × 20-minute sessions were
planned, but one was not carried out for personal reasons of the
trial author) and eight hours for Sargenti’s study (16 × 30-minute
sessions) (Christensen 1981; Fields 2003; Sargenti 2011). In the
studies by Fields 2003 and Sargenti 2011, the same length of time
(the first 10 minutes) was allocated to NSOMTs in each therapy
session. For Christensen 1981, the NSOMT was provided in the
first six weeks and at every other session over the following eight
weeks. The studies by Christensen 1981 and Sargenti 2011 used
individual therapy, whereas the study by Fields 2003 used group
therapy (two participants in each group).
Outcomes
Different tests were used as outcome measures. Christensen 1981
used the following tests for pre-treatment and post-treatment as-
sessments of articulation: (1) a word repetition test for evaluating
tongue-tip placement during production of /t/, /d/, /l/, /n/, /s/
and /z/ - one point for the error of dentalisation and two points
for the error of interdentalisation; (2) a “clinician-designed pic-
ture articulation test that elicited spontaneous production of 24
s-words and 8 z-words with the target phonemes occurring in all
positions and of 7 initial s-blends” (p 162) - one point for each
error (omission, substitution and distortion); and (3) GFTA First
Edition (GTFA-1) - one point for each error (omission, substi-
tution and distortion). Additional items were used for post-treat-
ment assessments of articulation: “(1) a sentence repetition series,
including a sentence loaded with each of the tongue-tip sounds
and devoid of /ð/ and / / phonemes; (2) counting from 50 to 70
and describing zoo and playground pictures to elicit numerous /
s/ and /z/ phonemes in conversation” (p 163), but the results were
not reported.
Fields 2003 used the Structured Photographic Articulation Test-
Dudsberry (SPAT-D; Kresheck 1989), whereas Sargenti 2011
used the “assessment of oral-motor functions during non-speech
tasks” (Mackie 1996, p 9) and GTFA Second Edition (GFTA-2)
(Goldman 2000). Three sets of probes (each of which includes
four words that contain /s/ and four that contain /z/) were devel-
oped by the trial author for tracking treatment progress for /s/ and
generalisation of treatment effect for /z/ (Sargenti 2011).
Excluded studies
We excluded 20 reports for various reasons.
• Two were not experimental studies (Bathel 2006; Karch
2005).
• One was not a treatment study but rather was a survey on
the use of NSOMTs by speech-language pathologists in Albert,
Canada, for treating children with speech disorders (Hodge
2005a).
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• Two did not use NSOMT for treatment (Clark 1993;
Helmick 1976).
• One did not treat speech sound disorders (Bacha 1999).
• Five were not randomised or quasi-randomised controlled
trials (Baskervill 1976; Forrest 2008; Gommerman 1995; Guisti
2002; Guisti Braislin 2005).
• Two did not conform with the types of interventions stated
in the protocol (Hayes 2006; Overstake 1976).
• One used a cross-over design (Roehrig 2004).
• Six were excluded for a combination of reasons as stated
above. Bäckman 2003 and Bäckman 2007 were not randomised
or quasi-randomised controlled trials; they did not treat speech
sound disorders and did not use NSOMT for treatment.
Carlstedt 2001 and Carlstedt 2003 did not treat speech sound
disorders and did not use NSOMT for treatment. Powers 1974
was not a randomised or quasi-randomised controlled trial and
did not treat speech sound disorders. Robertson 2001 was not a
randomised or quasi-randomised controlled trial, and the
participants were adults, not children.
Risk of bias in included studies
Results of the ’Risk of bias’ assessment are detailed in the ’Risk of
bias tables’ beneath the Characteristics of included studies tables.
These results are also presented as percentages in the ’Risk of bias
graph’ (Figure 2) and are summarised in the ’Risk of bias summary’
(Figure 3).
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
The three included studies used randomisation in assigning par-
ticipants to the intervention group and the control group; how-
ever, they used slightly different methods. In Christensen 1981,
the 10 participants were randomly assigned to one of the two
conditions; however, the study authors did not report how the
random sequence was generated or who did it, and so we judged
this study as having ’unclear’ risk of selection bias. In Fields 2003,
eight children were first placed into groups of two by their school-
based speech-language pathologist (not the trial author), accord-
ing to their age, disorder and individualised education plan (IEP)
goals. The same school-based speech-language pathologist then
randomly assigned groups to the intervention group or the control
group (Fields 2014 [pers comm]). Study authors did not describe
the person or the methods by which the random sequence was
generated; therefore this study was judged as having ’unclear’ risk
of selection bias. Sargenti 2011 used a random number table to
randomly assign the four participants to one of two groups, but
did not specify who conducted the random allocation. For this
reason, we judged this study as having ’low’ risk of bias on ran-
dom sequence generation and ’unclear’ risk of bias on allocation
concealment.
Blinding
Blinding of participants and of the intervention provider is not
possible, given the nature of the intervention; therefore we judged
all studies as having ’high’ risk of performance bias. However,
blinding of outcome assessors is possible and should be im-
plemented. Only one study (Christensen 1981) employed two
blinded outcome assessors; we rated this study as having ’low’ risk
of detection bias. The other two studies (Fields 2003; Sargenti
2011) did not identify the outcome assessor and did not report
blinding of the outcome assessor; we rated these studies as having
’unclear’ risk of detection bias.
Incomplete outcome data
Nomissing data or attrition was noted in any of the three included
studies; consequentlywe judged all three studies as having ’low’ risk
of bias in this domain. Although Fields 2003 planned 10 therapy
sessions, only nine were carried out because the trial author “did
not implement therapy one day due to personal reasons” (p 23). All
participants attended their nine therapy sessions. Participants in
the other two studies (Christensen 1981; Sargenti 2011) attended
all therapy sessions.
Selective reporting
All three included studies appear to be free of selective reporting
bias and thuswere judged as having ’low’ risk of bias in this domain.
Other potential sources of bias
As regards Fields 2003, we identified the possibility of unequal
baseline characteristics in the intervention group and the control
group. Results of the Structured Photographic Articulation Test-
Dudsberry (SPAT-D) before and after treatment for each partici-
pant were reported in the Master’s thesis (on p 20). Scores for the
four participants in the intervention group were 17, 38, 12 and
41, whereas scores for the four participants in the control group
were 64, 50, 30 and 18. Although information on how to interpret
these scores was not provided (e.g. it is unclear whether higher
scores mean better articulation skills), the two groups seemed to
show different SPAT-D results before treatment. Therefore, we
judged this study as being at ’high’ risk of other bias. The other
two studies (Christensen 1981; Sargenti 2011) appear to be free
of other potential sources of bias; thus we judged them as having
’low’ risk of bias in this domain.
Effects of interventions
All three included studies (Christensen1981; Fields 2003; Sargenti
2011) measured the primary outcome - correct articulation of
speech sounds. None of the studies measured the other primary
outcomes (speech intelligibility, speech physiology and adverse ef-
fects) or the secondary outcomes (listener acceptability, speech
naturalness or bizarreness and self-perception of change in artic-
ulation or speech intelligibility). We did not carry out a meta-
analysis on the primary outcome - correct articulation of speech
sounds - because different standardised and non-standardised tests
of articulation were used in the three studies. Christensen 1981
used a standardised test of articulation (GFTA First Edition) and
two non-standardised tests of articulation; investigators compared
(1) pre-intervention and postintervention test scores for the in-
tervention group and the control group (using the sign test), and
(2) differences in pre-intervention and postintervention test scores
between the intervention group and the control group (using the
Fisher exact probability test). Fields 2003 used a standardised test
of articulation (SPAT-D) and tested differences among four sets
of data: (1) pre-intervention test scores of the intervention group;
(2) post-intervention test scores of the intervention group; (3) pre-
intervention test scores of the control group and (4) postinter-
vention test scores of the control group (using one-way analysis
of variance (ANOVA)). Sargenti 2011 used a standardised test of
articulation (GFTA Second Edition) and a non-standardised test
of articulation, but researchers did not use inferential statistics to
compare the intervention group against the control group, or pre-
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intervention performance against postintervention performance.
We describe below the results reported for each included study.
Primary outcomes
Correct articulation of speech sounds as measured by
standardised and/or non-standardised articulation test(s)
Different standardised tests were used in the three studies to assess
treatment outcome. For Christensen 1981, the First Edition of the
GFTA (total number of phoneme errors as assessed by the test) and
two other non-standardised tests of articulation (tongue-tip sound
placement, total number of /s/ and /z/ errors) were conducted be-
fore and after the intervention was provided. Study authors re-
ported that results of the sign test (P value not reported) showed
that “performance of both groups was significantly improved” post
intervention, as measured by these three tests of articulation. In
addition, results of the Fisher exact probability test (significance
level at 0.05) showed “observed [pre- and post-intervention test
scores] differences [between the two groups] to be not significant”
for each of those three outcomes (p 163).
In Fields 2003, the SPAT-D (Kresheck 1989) was conducted be-
fore and after the intervention with participants in the interven-
tion group and the control group. Study authors reported the fol-
lowing: “A one-way Analysis of Variance revealed a significant dif-
ference between the groups, p < .05, p = .0001” (Fields 2003, p
20). In the Discussion section of the paper, study authors stated
that “An ANOVA revealed a significant difference between the
groups’ pre-test and post test scores...” (p 21). The report of statis-
tical test results was ambiguous - it remains unclear whether a dif-
ference between the two groups was evident in the postinterven-
tion assessment, or whether differences between pre-intervention
and postintervention performance could be seen for each group.
Moreover, given the small sample size and the research design used
(two-arm pre/post study), one-way ANOVA was not an appropri-
ate test for assessing differences between groups and within par-
ticipants.
In Sargenti 2011, investigators conducted two tests - (1) “assess-
ment of oral-motor functions during non-speech tasks” (Mackie
1996) and (2) GFTA-2 (Goldman 2000) - one week before and
one week after the intervention was provided. In addition, they
developed three sets of probes (each of which included four words
that contain /s/ and four that contain /z/) for tracking treatment
progress of /s/ and generalisation of treatment effect of /z/. They
used probe one with all participants at the start of the first therapy
session to determine the initial level of performance; they used
probe two to record performance at the end of the first therapy
session, and probe three to document performance at the end of
the second therapy session. They assessed performance at the end
of the remaining therapy sessions by alternating use of the three
probes. Researchers calculated no inferential statistics to compare
the intervention group against the control group, nor pre-inter-
vention performance against postintervention performance. The
trial author reported that participants in both intervention groups
and control groups “manifested more non-speech oral tasks ade-
quately” post intervention as judged by assessment of oral-motor
functions during non-speech tasks (p 47). According to the re-
sults of GFTA-2, one participant in the intervention group (C1)
showed fewer articulation errors post interventionbut no improve-
ment in the treatment target /s/ and the non-treatment target /z/.
The other participant in the intervention group (C2) also showed
fewer articulation errors post intervention and “achieved correct
production of the targeted /s/ and the non-targeted /z/ sounds in
initial, medial and final word positions” (Sargenti 2011, p 44).
One participant in the control group (T1) showed the same articu-
lation errors post intervention, whereas the other participant (T2)
showed fewer articulation errors post intervention and “achieved
correct production of the targeted /s/ sound in initial, medial, and
final word positions as well as the non-targeted /z/ sound in initial
and medial word positions” (Sargenti 2011, p 43). Results of the
s/z probes showed that C1 in the intervention group scored zero
for both /s/ and /z/ during the course of the intervention and C2
reached 100% in session 11 for /s/ and made “steady progress” for
/z/ (Sargenti 2011, p 46). In the control group, T1 scored zero for
both /s/ and /z/, whereas T2 reached 100% in session six for /s/
and showed “steady progress” for /z/“ (Sargenti 2011, p 46).
None of the included studies provided information on effect sizes
and 95% confidence intervals.
None of the included studies examined the impact of NSOMTs
on the remaining primary outcomes - speech intelligibility, speech
physiology and adverse effects.
Secondary outcomes
None of the included studies examined the impact of NSOMTs
on any of the secondary outcomes: listener acceptability, speech
naturalness or bizarreness and self perception of change in articu-
lation or speech intelligibility.
D I S C U S S I O N
Summary of main results
The search of the literature yielded several intervention studies
that investigated the effectiveness of non-speech oral motor treat-
ments (NSOMTs), but only three studies (from four reports), in-
volving 22 children, met the inclusion criteria (Christensen 1981;
Fields 2003; Sargenti 2011). Sargenti 2011, a randomised con-
trolled trial (RCT), randomly assigned participants to one of the
two intervention conditions using a random number table. The
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other two studies (Christensen 1981; Fields 2003) stated that ran-
dom allocation of participants was conducted but did not report
the details of sequence generation. Hence, we judged them to be
quasi-randomised controlled trials. None of the included studies
reported themethod used for concealing allocation of participants;
hence, we judged risk of allocation concealment as unclear for all
three included studies.
We did not conduct a meta-analysis, as the included studies used
different outcome measures. The three studies showed different
findings as regards the efficacy of NSOMTs for treating develop-
mental speech sound disorders. Christensen 1981 reported differ-
ences between pre-intervention and postintervention assessments
of articulation for both intervention and control groups using the
sign test (significance level not reported). However, researchers
noted no differences between the two groups in terms of pre-inter-
vention and postintervention test scores as assessed by the Fisher
exact probability test at a significance level of 0.05. Hence, the
study authors concluded that participants ”in both groups made
essentially the same progress in correcting tongue-tip sound place-
ment, remediating /s/ and /z/ misarticulations and remediating
general articulation errors“ (p 163).
Fields 2003 (p 20) reported that ”A one-way Analysis of Vari-
ance revealed a significant difference between the groups, p < .05,
p = .0001“. Also, in the Discussion section of the paper, study
authors stated that ”An ANOVA revealed a significant difference
between the groups’ pre-test and post test scores indicating the
possibility that the implementation of ten minutes of oral motor
therapy prior to ten minutes of articulation of phonology therapy
appeared to increase correct productions of phonemes for the four
participants in Group A (the intervention group)“ (Fields 2003, p
21). Statistical test results were not clearly presented and one-way
ANOVA was not an appropriate test for a study of this research
design - two-arm pre/post study.
Sargenti 2011 found that ”similar improvements were made by
the subjects who received OMT in conjunction with articulation
therapy as compared to those who received articulation alone“ (p
62). Thus, trial authors concluded that ”OMT used in conjunc-
tion with articulation therapy is not more effective than articula-
tion therapy alone in the treatment of speech sounds disorders for
children who exhibit delayed oral motor control“ (p 62).
Overall completeness and applicability of
evidence
The overall applicability of evidence is limited and incomplete.
This review identified three small-scale randomised or quasi-ran-
domised controlled trials that investigated the efficacy of NSOMT
as adjunctive treatment to conventional speech intervention for
children between three and nine years of age with speech sound
disorders (Christensen 1981; Fields 2003; Sargenti 2011). Speech
problems of children in the three studies seemed to be unrelated to
any obvious structural, neuromuscular, sensory or intellectual im-
pairment. Therefore, it is uncertain whether the evidence could be
generalised to individuals who have speech sound disorders with
organic causes. Furthermore, the speech sound targeted in therapy
in the three studies was limited to one or two speech sounds - both
/s/ and /z/ were treated in one study (Christensen 1981), whereas
only /s/ was treated in the other studies (Fields 2003; Sargenti
2011). These sounds - /s/ and /z/ - are often targeted for treatment
in speech therapy, as they are a common source of speech errors
(Gibbon 2006). However, the limited range of NSOMTs targeted
means that, even though the three studies used different treatment
packages as NSOMTs, we are uncertain whether current evidence
could be generalised to other speech sounds and other treatment
exercises (e.g. sensory stimulation using massage).
Quality of the evidence
We noted several limitations in the methodology of the included
studies (Christensen 1981; Fields 2003; Sargenti 2011). First, the
sample size of each of the included studies was very small - 10
participants in Christensen 1981, eight in Fields 2003 and four in
Sargenti 2011 - and none of the studies attempted to calculate the
sample size required before recruiting participants. Small sample
sizes are highly unlikely to be representative of the study popula-
tion, and this affects the validity of conclusions that can be drawn
regarding treatment efficacy (Nelson 2009). Second, studies were
at unclear risk for selection bias given that methods used to gener-
ate the random sequence were not reported in two of the included
studies (Christensen 1981; Fields 2003), and none of the studies
provided details of allocation concealment. In addition, two stud-
ies were at unclear risk of detection bias, as they did not report the
use of blinded outcome assessors (Fields 2003; Sargenti 2011). An-
other matter of concern involved unequal baseline characteristics
of participants in the intervention group and in the control group
in one of the included studies (Fields 2003), as suggested by re-
sults of the articulation test (SPAT-D). Third, no inferential statis-
tics were calculated to compare the intervention group against the
control group, or pre-intervention performance against postinter-
vention performance, in one study (Sargenti 2011).What is more,
another study used an inappropriate statistical test and did not
clearly report results of the statistical test (Fields 2003), and in
the two studies that conducted inferential statistics (Christensen
1981; Fields 2003), reporting of statistical test results was incom-
plete (e.g. effect sizes were not reported, significance level was not
reported for one test). Finally, the fact that two studies (Fields
2003; Sargenti 2011)were research projectswritten asMaster’s the-
ses, which have not been subsequently published in peer-reviewed
journals, further compromises the quality of evidence provided by
these studies. In the light of serious limitations in methodology,
we judged the overall quality of the evidence provided by the in-
cluded trials to be low. Therefore, further research is very likely
to have an important impact on our confidence in the estimate
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of treatment effect and is likely to change the estimate (Guyatt
2008).
Potential biases in the review process
To identify all relevant studies, we conducted comprehensive
searches, contacted colleagues and researchers for grey literature
and checked the reference lists of related articles. We searched five
additional relevant electronic databases that were not listed in the
protocol, as recommended by the Trials Search Co-ordinator of
the Cochrane Developmental, Psychological and Learning Prob-
lems Group. We adhered to our published protocol (Lee 2011)
as much as possible throughout the review process - two review
authors independently screened titles and abstracts to eliminate
irrelevant titles, judged whether remaining titles met the inclusion
criteria and resolved differences of opinion by discussion. There-
fore, it seems unlikely that an important trial was omitted. An-
other strength of the present research is that we conducted the risk
of bias assessment of all included studies using full-text versions
of the titles. Furthermore, the review authors declared that no di-
rect funding was received for conducting this review and noted no
potential of conflicts of interest.
One limitation of this review is that we were not able to contact
the authors of two studies regarding issues of random sequence
generation and allocation concealment (Christensen 1981), and
whether allocation concealment was ensured (Sargenti 2011). We
were able to contact the author of the Fields 2003 study; however,
information regarding random sequence generation method and
allocation concealment was not provided. Hence, we were unable
to classify the studies by Christensen 1981 and Fields 2003 as
RCTs. Another limitation is that we were unable to conduct a
meta-analysis, as different outcome measures were used in the
three included studies. Therefore, the conclusions of this review
are based on a qualitative analysis of the included studies.
Agreements and disagreements with other
studies or reviews
Three previous systematic reviews examined the efficacy of
NSOMTs. The first was conducted in 2008 by Lass and
Pannbacker (Lass 2008), who searched for NSOMT studies on
treating phonological disorders using two databases (MEDLINE
and Cumulative Index to Nursing and Allied Health Literature
(CINAHL)). Their search strategies yielded nine articles, and re-
view authors evaluated the level of evidence for each of these
nine treatment studies. The second review was conducted by Mc-
Cauley and colleagues (McCauley 2009), who searched 19 elec-
tronic databases and other literature sources to identify studies
written in English and published in peer-reviewed journals be-
tween 1960 and 2007 that addressed at least one of the following
questions: (1) What is the influence of oral motor exercises on
speech physiology? (2) What is the influence of oral motor exer-
cises on sound production? and (3) What is the influence of oral
motor exercises on functional speech outcomes? Review authors
identified and reviewed a total of 15 titles. The third review, which
was conducted in 2010, used similar procedures to the second re-
view (Ruscello 2010). The review author searched 21 electronic
databases and other relevant literature sources to identify peer-re-
viewed English literature published during the same period (1960
to 2007) that addressed one of the following questions: (1) Does
oral motor exercise have a positive effect on speech physiology?
(2) Does oral motor exercise have a positive effect on speech pro-
duction? or (3) Is oral motor exercise effective when examined
through functional speech outcomes such as measures of intelligi-
bility? This review also identified 15 titles.
The present review identified one randomised controlled trial
(Sargenti 2011) and two quasi-randomised controlled trials (
Christensen 1981; Fields 2003). The study by Christensen and
Hanson (Christensen 1981) was included in the three previous re-
views, whereas the other two studies (Fields 2003; Sargenti 2011)
were not. Studies included in previous reviews were excluded from
the present review (except one) because most were case studies,
participants were not children or treatment did not target speech
sound disorders (e.g. voice disorder was treated). The discrepancy
in search results between previous reviews and the present review
was probably due to the greater number of electronic databases
searched in this review and the different inclusion criteria used.
Despite different search results, the findings of this review are con-
sistent with those of the three previous reviews in that method-
ological limitations are evident in the included studies, including
small sample size; unclear randomisation method; insufficient de-
scription of protocols, interventions and participant characteris-
tics; different baseline characteristics between treatment group and
control group; and lack of blinding of outcome assessor(s) (Lass
2008; McCauley 2009; Ruscello 2010). In addition, and consis-
tent with previous findings, this review did not identify a study
that compared NSOMT only versus conventional speech inter-
vention only. This type of comparison is important for evaluating
the absolute efficacy of NSOMTs (McCauley 2009). Overall, the
present review concurs with previous reviews that no strong evi-
dence is available to support the efficacy of NSOMTs for treating
children with speech sound disorders.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review identified three small-scale studies that investigated
the efficacy of NSOMT as adjunctive treatment to conventional
speech intervention for children with speech sound disorders
(Christensen 1981, Fields 2003; Sargenti 2011). Two studies
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(Christensen 1981; Sargenti 2011) did not find NSOMT as ad-
junctive treatment to be more effective than conventional speech
intervention, as intervention and control groups showed similar
improvements in articulation after treatment. One study (Fields
2003) reported a change in postintervention articulation test re-
sults, but an inappropriate statistical test was used and study re-
sults were not reported clearly.
Reports of the three studies suggest that each had methodological
limitations. As well as small sample sizes, the participant group
was limited to children with speech sound disorders of unknown
origin, and the target for treatment was limited to /s/ and /z/. In
addition, reports often provided little or no information about im-
portant risks of bias such as allocation concealment and random
sequence generation. Masking of outcome assessors was not re-
ported in two of the studies; two used inferential statistics but did
not include full details of statistical test results; and one study used
an inappropriate statistical test. Overall, the evidence is limited
and incomplete. Thus, findings of the present review are consistent
with those of previous research, which currently provide no strong
evidence suggesting thatNSOMTs are effective as treatment or ad-
junctive treatment for children with developmental speech sound
disorders.
Implications for research
A five-phase model has been proposed to test the efficacy and ef-
fectiveness of intervention approaches for managing communi-
cation disorders (Robey 2004). Results of this review show that
NSOMTs are in the first phase of this clinical outcome research
model, that is, the stage of investigating whether a therapeutic
effect is present and subsequently estimating the magnitude of
this therapeutic effect if present (Robey 2004). As several method-
ological limitations have been associated with previous treatment
studies of NSOMTs, further well-designed research is needed to
answer the question of whether NSOMTs have a therapeutic ef-
fect in children with developmental speech sound disorders at this
pretrial phase. The following methodological issues identified in
this review should be addressed in future research: sample size; the
need for a clear description of the method used to generate the
randomisation sequence and allocation concealment; blinding of
outcome assessor(s); comparable baseline characteristics between
treatment groups and control groups; a detailed description of
baseline characteristics of all participants; a detailed description of
interventions used and reports on whether the intervention plan
was adhered to; appropriate statistical analysis and complete re-
porting of statistical test results; and inclusion of both primary
and secondary outcome measures. It is recommended that future
research teams should include expert(s) in randomised controlled
trial design and statistics to ensure the quality of research method-
ology. Research designs such as well-controlled single case studies
and small-group pre/post studies would be useful for pretrial re-
search (McCauley 2009; Robey 2004).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Christensen 1981
Methods Quasi-randomised controlled trial comparing 1 intervention group (a combination of
articulation and oral myofunctional (tongue thrust) therapy) and 1 control group (ar-
ticulation therapy only). (The date of the study was not reported.)
Participants 10 children (6 boys and 4 girls) aged 5 years 8months to 6 years 9months. All participants
had ”normal hearing as measured by puretone screening tests, normal development as
reported by parents, no other knownphysical or psychological abnormalities, no previous
speech or tongue thrust services, willingness of the parents to cooperate and carry out
daily home practice sessions, and white middle-class home environment“ (p 161). In
addition, ”all children...were observed by the investigator to have visually and acoustically
distorted /s/ and /z/, 2 or more other dentally or interdentally produced tongue-tip
sounds (although acoustically correct) and interdental tongue positioning on swallows
of all 3 swallowing media (liquid, solids and saliva)“ (p 162)
Interventions The 10 participants were randomly assigned to 1 of 2 groups
Intervention group (n = 5)
• A total of 22 × 30-minute therapy sessions conducted weekly in the first 6 weeks
and twice a week in the following 8 weeks
• Oral myofunctional therapy was administered in the first 6 weeks and in the
following 8 weeks; alternating sessions of oral myofunctional therapy and articulation
therapy were conducted. The ”Hanson’s 1977 approach“ (Barrett 1978), which
employs neuromuscular facilitation techniques, was used for oral myofunctional
therapy for treating /s/ and /z/
Control group (n = 5)
• A total of 22 × 30-minute therapy sessions conducted weekly in the first 6 weeks
and twice a week in the following 8 weeks
• Articulation therapy was conducted according to the following steps: ”(1)
auditory identification of correct and incorrect /s/ and /z/; (2) isolated production of
both sounds; (3) production of syllables in initial, medial, and final positions; (4)
production in words in all positions and in blends; (5) use in short carrier-phrase
sentences (e.g., I see a ); (6) use in describing pictures; and finally, (7) normal usage
in telling stories and in conversation. Each subject was allowed to progress as fast as he
or she was able to master correct production at each step in the sequence“ (p 162)
At the start of the intervention, about 1.5 to 2.5 therapy sessions were devoted to
articulation therapy targeting the placement of speech sounds /t/, /d/, /l/ and /n/ for all
participants. As stated above, the frequency of therapy sessions was the same for both
intervention and control groups. Total therapy time was 11 hours for each participant.
All participants ”were given weekly home assignments to be completed with themother’s
help in brief, daily home practices“ (p 162). ”Articulation home assignments“ and home
assignments for oral myofunctional therapywerementioned, but it was not clear whether
the intervention group was given both home assignments and the control group was
given only articulation home assignments (p 162)
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Christensen 1981 (Continued)
Outcomes The following tests were used for pretreatment and post-treatment assessments of artic-
ulation
• A word repetition test for evaluating tongue-tip placement during production of /
t/, /d/, /l/, /n/, /s/ and /z/
• A ”clinician-designed picture articulation test that elicited spontaneous
production of 24 s-words and 8 z-words with the target phonemes occurring in all
positions and of 7 initial s-blends“ (p 162)
• Goldman-Fristoe Test of Articulation (first edition)
Additional items were used for post-treatment assessments of articulation
• ”(1) a sentence repetition series, including a sentence loaded with each of the
tongue-tip sounds and devoid of /ð/ and // phonemes; (2) counting from 50 to 70 and
describing zoo and playground pictures to elicit numerous /s/ and /z/ phonemes in
conversation“ (p 163)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The method used to generate the random
sequence was not described
Allocation concealment (selection bias) Unclear risk The method used to conceal allocation was
not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of participants and personnel was
not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinding of the outcome assessor was en-
sured - ”pre- and post-treatment test re-
sponses were evaluated by two independent
observers... Neither judge knewwhich chil-
dren were receiving tongue-thrust services“
(p 162)
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed the 22 therapy
sessions
Selective reporting (reporting bias) Low risk The study appears to be free of selective
reporting bias
Other bias Low risk The study appears to be free of other bias
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Fields 2003
Methods Quasi-randomised controlled trial comparing 1 intervention group (oral motor therapy
and articulation or phonological therapy) and 1 control group (articulation or phono-
logical therapy only). Conducted in 2002
Participants 8 children (4 boys and 4 girls) aged between 3 and 6 years; mean age was 4.63 years.
All participants had not received oral motor therapy before the study. All had a current
IEP with speech and language assessment no more than 1 year old, and all had been
receiving articulation therapy for at least 3 months. Receptive vocabulary score on the
PPVT-III was within normal limits, and the standard score on SPAT-D fell within 1.
5 and 2 standard deviations below the mean. All participants were diagnosed as having
moderate to severe articulation disorder. In the intervention group, participants 1, 2 and
3 showed ”cluster reduction /s/ errors“ and participant 4 had ”stridency deletion“ (p 18);
it was not reported whether additional speech errors were observed in these participants.
Investigators did not report speech errors shown by participants in the control group
Interventions 8 children were placed first into 4 groups (2 in each group) according to age, disorder and
IEP goals by the speech-language pathologist at the school the children were attending.
Groups were then randomly assigned to 1 of 2 conditions
Intervention group (n = 4)
• 9 × 20-minute therapy sessions with the first 10 minutes on oral motor therapy
and the following 10 minutes on articulation or phonological therapy
• Oral motor exercises for speech clarity, as developed by Sara Rosenfeld-Johnson
(Rosenfeld-Johnson 2001), were used for oral motor therapy. This treatment protocol
includes exercises for the jaw, lips and tongue. Exercises used in the intervention were
selected on the basis of oral motor weakness identified in individual participants and
the phoneme(s) that were misarticulated. Hence, tongue exercises were administered to
participants 1 and 2, whereas jaw exercises were given to participants 3 and 4.
Participant 1 completed the 4 steps in the first exercise - ”tongue-tip lateralisation
midline to either side“ - and the first 2 steps (6 steps altogether) of the second exercise -
”tongue-tip lateralisation across midline“. Participant 2 completed the 4 steps of the
first tongue exercise and the first step of the second tongue exercise. Participants 3 and
4 completed the first 2 of the 3 steps of the ”Bite Block #2“ exercise. The phonological
processes shown by participants (see above) were targeted in the articulation or
phonological therapy
Control group (n = 4)
• 9 × 20-minute therapy sessions using articulation or phonological therapy
depending on the diagnoses of individual children
• The phoneme(s) targeted in therapy were not reported
10 therapy sessions were planned; however, only 9 were administered because the ”re-
searcher did not implement therapy one day due to personal reasons“ (p 23). The fre-
quency of therapy sessions was the same for both intervention and control groups: 2
therapy sessions per week, over 5 weeks. Total therapy time was 3 hours for each partic-
ipant. All therapy sessions, for both conditions, were carried out in groups of 2 children
Outcomes SPAT-D was conducted pre-intervention and post intervention to measure treatment
effect
Notes
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Fields 2003 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The method used to generate the random
sequence was not described
Allocation concealment (selection bias) Unclear risk The method used to conceal allocation was
not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of participants and personnel was
not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessor was not identified
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed the 9 therapy
sessions
Selective reporting (reporting bias) Low risk The study appears to be free of selective
reporting bias
Other bias High risk Query the possibility of unequal baseline
characteristics of the 2 groups - the inter-
vention group had a mean score of 27 and
an SD of 14.6 for SPAT-D pre-treatment,
whereas the control group had amean score
of 40.5 and an SD of 20.5 for SPAT-D.
The intervention group appeared to have
fewer speech errors than the control group
at the start of the study
Sargenti 2011
Methods Randomised controlled trial comparing 1 intervention group (oral motor therapy and
articulation therapy) and 1 control group (articulation therapy only). Conducted from
January to March 2011
Participants 4 children (all boys) aged 7.01 to 9.06 years; mean age was 8.02 years. All participants
had normal hearing and showed delayedmotor control. 1 participant in the intervention
group was diagnosed as ”communication impaired“, and 1 participant in the control
group was classified as ”multiply disabled (communication impaired, Attention Deficit
HyperactivityDisorder, Tourette Syndrome, andObsessive-CompulsiveDisorder)“. The
other 2 participants had ”normal academic and language abilities“ (p 17). All participants
showed ”distorted production of the phonemes /s/ and /z/ and exhibited an interdental
(frontal) or lateral lisp“ (p 17)
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Sargenti 2011 (Continued)
Interventions The 4 participants were randomly assigned to 1 of the 2 groups by means of a random
number table
Intervention group (n = 2)
• 16 × 30-minute therapy sessions, with the first 10 minutes on oral motor therapy
and the following 20 minutes on articulation therapy
• Oral placement therapy (OPT) for /s/ and /z/, developed by Rosenfeld-Johnson
(Rosenfeld-Johnson 2009), was used for oral motor therapy. This treatment protocol
includes exercises for the jaw, lips and tongue, using the following tools - Talk Tools
Jaw Grading Bite Blocks, Talk Tools Bubble Kit and Talk Tools Horn Kit - as well as a
sensory programme using Talk Tools Vibrator/Toothettes. Exercises used in the
intervention were selected on the basis of results of the Initial Speech System Evaluation
(which comes with this treatment package) of individual participants. Hence,
participant 1 went through the following exercises during the course of intervention:
bite block exercises level #2 to #7, blow bubble exercises level #3 to #5 and blow horn
exercises level #2 to #12, whereas participant 2 went through bite block exercises level #
4 to #7 and blow horn exercises level #9 to #12. Results of the Initial Speech System
Evaluation revealed that both participants had ”hypo-sensitivity/responsivity“ (p 22).
Thus, the sensory programme was administered to participants at the start of each
therapy session ”to increase awareness“ before oral motor therapy (p 26). The
programme started with rubbing both sides of the buccal cavity, the upper and lower
gum ridges, the surface and lateral margins of the tongue and the hard palate of the
participant with a dampened Talk Tools Toothette; the procedure was repeated using a
Talk Tools Vibrator. The sensory programme took about 1 to 2 minutes to complete
Control group (n = 2)
• 16 × 30-minute therapy sessions with articulation therapy, targeting /s/ at
different word positions
The frequency of therapy sessions was the same for both intervention and control groups
- 2 therapy sessions per week over 8 weeks. Total therapy time was 8 hours for each
participant. All therapy sessions were conducted as individual therapy. All participants
were ”given specific articulation homework assignments biweekly“ (p 38) and ”specific
(oral motor therapy) homework assignments were given biweekly“ to participants in the
Intervention group (p 30)
Outcomes Assessment of Oral-Motor Functions During Non-Speech Tasks (Mackie 1996) and
Goldman-Fristoe Test of Articulation Second Edition (Goldman 2000) were conducted
on all participants 1 week before the intervention and 1 week after the final therapy
session. 3 sets of probes (each of which includes 4 words that contain /s/ and 4 words that
contain /z/) were developed for tracking treatment progress of /s/ and generalisation of
treatment effect to /z/. Probe 1 was conducted on all participants at the start of the first
therapy session to determine the initial level of performance; probe 2 was used to record
performance at the end of the first therapy session; and probe 3 was used to document
performance at the end of the second therapy session. Performance at the end of the
remaining therapy sessions was assessed by alternating use of the 3 probes
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Sargenti 2011 (Continued)
Random sequence generation (selection
bias)
Low risk ”A random number table was used to ran-
domly assign subjects to one of two groups“
(p 18)
Allocation concealment (selection bias) Unclear risk The method used to conceal allocation was
not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of participants and personnel was
not possible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessor was not identified
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants completed the 16 therapy
sessions
Selective reporting (reporting bias) Low risk The study appears to be free of selective
reporting bias
Other bias Low risk The study appears to be free of other bias
IEP = individualised education plan; PPVT-III = Peabody Picture Vocabulary Test Third Edition; SPAT-D = Structured Photographic
Articulation Test - Dudsberry.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bacha 1999 Investigators did not treat speech sound disorders. Breathing, feeding, oral-facial habits, buccal hygiene and
corporal posture or physical activity were treatment targets
Baskervill 1976 Not a randomised or quasi-randomised controlled trial. The study used a pretest/post-test design with no
control group
Bathel 2006 Not an experimental study. This article described current research in the field of oral-motor muscle-based
therapies
Bäckman 2003 Not a randomised or quasi-randomised controlled trial; investigators did not treat speech sound disorders,
and treatment used was not NSOMT. This case-control study included 42 children with Down syndrome in
the experimental group (age-matched to 31 typically developing children (control group 1)) and 33 children
with Down syndrome (control group 2). Researchers investigated the effects of a palatal plate on several
dental outcomes (e.g. eruption of teeth, sucking habits, tongue morphology, overjet and overbite), oral motor
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function and speech production
Bäckman 2007 Not a randomised or quasi-randomised controlled trial; investigators did not treat speech sound disorders,
and treatment used was not NSOMT. This was a case-control study. Participants in the experimental group
(n = 38) also took part in the Bäckman 2003 study. Researchers investigated the effects of palatal plate on
several dental outcomes (e.g. eruption of teeth, sucking habits, tongue morphology, overjet and overbite), oral
motor function and speech production
Carlstedt 2001 Investigators did not treat speech sound disorders, and treatment used was not NSOMT. Researchers investi-
gated the effects of palatal plate on facial expression and oral motor function during silence and speech
Carlstedt 2003 Investigators did not treat speech sound disorders, and treatment used was not NSOMT. Researchers in-
vestigated the effects of palatal plate on oral facial structure appearance, oral motor function, speech sound
articulation and communication preferences
Clark 1993 Treatment used was not NSOMT. Researchers investigated the effects of a removable prosthetic appliance for
treating distortion or substitution errors for /r/, or both
Forrest 2008 Not a randomised or quasi-randomised controlled trial. Investigators used a pretest/post-test ”alternating
treatment design“ whereby all participants received (1) NSOMT for treating 1 speech sound, (2) speech
intervention (”traditional production treatment“) for treating a second, linguistically unrelated sound and (3)
no treatment for a third sound, which served as a control for non-experiment effects (p 307)
Gommerman 1995 Not a randomised or quasi-randomised controlled trial. This was a single case study
Guisti 2002 Not a randomised or quasi-randomised controlled trial. Investigators used a pretest/post-test design with no
control group
Guisti Braislin 2005 Not a randomised or quasi-randomised controlled trial. Investigators used a pretest/post-test design with no
control group. Note that this study (a Master’s thesis) was identical to Guisti 2002
Hayes 2006 Trial did not conform with the types of interventions stated in the protocol. Although participants were
randomly assigned to 1 of the 2 intervention conditions, NSOMT was used in both interventions - 1 group
received baseline, followed by traditional articulation treatment only, combined traditional articulation treat-
ment and NSOMT and traditional articulation treatment only. The other group received baseline, followed
by NSOMT only, combined traditional articulation treatment and NSOMT and NSOMT only
Helmick 1976 Treatment used was not NSOMT. Researchers investigated the effects of conventional speech intervention in
remediating articulation errors in children with speech sound disorders
Hodge 2005a Not a treatment study. This study is a survey on the use of NSOMTs by speech-language pathologies in
Alberta, Canada, for the treatment of speech disorders in children
Karch 2005 Not an experimental study. The article describes orofacial regulation therapy
Overstake 1976 Trial did not conform with the types of interventions stated in the protocol. Investigators compared ”swallow
therapy only“ vs ”swallow and speech therapy“
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Powers 1974 Not a randomised or quasi-randomised controlled trial; investigators did not treat speech sound disorders.
Researchers used a pretest/post-test design for investigating the effects of muscle exercises in treating hyper-
nasality
Robertson 2001 Not a randomised or quasi-randomised controlled trial; participants were adults, not children. Researchers
used a pretest/post-test design
Roehrig 2004 Cross-over design was used
NSOMT = non-speech oral motor treatment.
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Methods planned in the protocol but not used in this review
Issue Method
Measures of treatment effect Binary and categorical data
Binary data (e.g. articulation improved vs no change) are likely. We will
analyse the data by calculating the risk ratio (RR)
Continuous data
Most data from expected outcome measures, such as standardised artic-
ulation test results, articulation accuracy based on perceptual evaluation,
judgement of speech intelligibility and listener acceptability, are likely to
be continuous data. We will calculate the mean difference (MD, or the
‘difference inmeans’) when outcomemeasurements in all studies are made
on the same scale. Otherwise, we will use standardised mean differences
(SMDs) to combine studies that measured the same outcome using dif-
ferent methods
Unit of analysis issues Cluster-randomised trials
We may include cluster-randomised trials in this review. In this case,
appropriate statistical approaches should be used, for example, using a 2-
sample t-test to compare the means of clusters in the intervention group
vs those in the control group at cluster level, or a mixed effects linear
regression approach at an individual level (Donner 2000).We will contact
trial author(s) if it is unclear whether appropriate adjustments have been
made (Donner 2000). When individual level data cannot be secured, we
will control the data for the clustering effect by using the procedures
described in theCochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011). For dichotomous data, we will divide the number of
participants and the number experiencing the event by the design effect,
1 + (M-1) * ICC, where M is the average cluster size and ICC is the
intracluster correlation coefficient. For continuous data, we will divide
the number of participants by the design effect, with means and standard
deviations remaining unchanged. We will combine the results with those
from individually randomised trials for meta-analysis using the generic
inverse-variance method in RevMan when clinical heterogeneity between
studies is small (Donner 2000; Higgins 2011)
Multi-arm studies
For studies with more than 2 intervention groups (i.e. multi-arm studies)
, we will combine groups to create a single pair-wise comparison (Higgins
2011). We will combine all relevant experimental intervention groups to
form a single group, and we will combine all relevant control groups and
placebo groups to form a single control group. To avoid confusion over
the nature of each study, we will mention all intervention groups of a
multi-arm study in the ’Notes’ section of the Characteristics of included
studies table. We will provide detailed descriptions of intervention groups
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Table 1. Methods planned in the protocol but not used in this review (Continued)
relevant to the review in the ’Interventions’ section of the table
Cross-over trials
Cross-over trials are not appropriate for an intervention that can have a
lasting effect (Higgins 2011). Therefore, this design is not suitable for
studying speech intervention, andwewill not include in this review studies
that applied this design
Dealing with missing data We will assess missing data and dropouts for each included study and
will report the reasons for and numbers and characteristics of dropouts.
When possible, we will contact trial author(s) to supply the missing data
and any relevant information. If the missing data appear to be missing at
random (e.g. data lost because of computer problems), we will conduct
an analysis on available data (Higgins 2011). However, if the data are
not missing at random, we will conduct the analysis by imputing the
missing data with replacement values. For dichotomous data, we will use
a sensitivity analysis based on consideration of ‘best-case’ and ‘worst-case’
scenarios to assess the extent to which the results of the review could
be altered by the missing data (Gamble 2005). The ‘best-case’ scenario
means that all participants with missing outcomes in the intervention
group had good outcomes (e.g. improvement in articulation) and those
with missing outcomes in the control group had poor outcomes (e.g. no
improvement in articulation); the ‘worst-case’ scenario is the reverse. For
missing continuous data, we will conduct the analysis by imputing the
missing data with replacement values (e.g. last observation carried forward
(LOCF), mean of the treatment group) and treating these as if they were
observed (Higgins 2011). We will address in the Discussion section the
potential impact of missing data on the findings of the review
Assessment of heterogeneity Variability in participants, interventions and outcomes between the dif-
ferent included studies is known as clinical heterogeneity, and variabil-
ity in the intervention effects being evaluated in the included studies is
known as statistical heterogeneity, or simply as heterogeneity (Higgins
2011). Clinical heterogeneity will lead to statistical heterogeneity if the in-
tervention effect is influenced by factors such as participant characteristics
(Higgins 2011). We will assess statistical heterogeneity by using the Chi2
test for heterogeneity, by visually inspecting forest plots and by using the
I2 statistic (Higgins 2002; Higgins 2003). The Chi2 test assesses whether
observed differences in results are compatible with chance alone (Higgins
2011). However, this test has low power if the meta-analysis includes only
a small number of studies, or if the included studies have small sample
sizes. In this case, a P value of 0.10 (rather than the conventional level of 0.
05) will be used to determine statistical significance (Higgins 2011). I2 is
a statistic for assessing the impact of inconsistency across studies through
the meta-analysis. We will follow the rough guide to interpretation of the
I2 statistic as stated in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). However, thresholds for interpretation of
the I2 statistic may be misleading. We will take into account other issues,
such as magnitude and direction of effects and strength of evidence for
heterogeneity (e.g. the P value from the Chi2 test), when determining the
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Table 1. Methods planned in the protocol but not used in this review (Continued)
importance of the observed value of the I2 statistic (Higgins 2011)
Assessment of reporting biases Funnel plots (effect size vs error) will be drawn if sufficient studies are
found. An asymmetrical funnel plot indicates a relationship between effect
size and study size, which suggests the possibility of publication bias or a
systematic difference between smaller and larger studies. If a relationship
is identified, the clinical diversity of the studies will also be examined
(Egger 1997)
Data synthesis We will carry out a meta-analysis using Review Manager version 5.1
(RevMan) if data are sufficient and if the interventions are similar in terms
of characteristics of the participants, types of non-speech oral motor treat-
ments (NSOMTs) used, the schedule (e.g. frequency and duration) of
the treatment and outcome measures. We will apply both a fixed-effect
model and a random-effects model and will compare the results to assess
the impact of statistical heterogeneity.We will present the results from the
random-effects model unless contraindicated (e.g. in cases of funnel plot
asymmetry). In the case of serious funnel plot asymmetry, we will present
both fixed-effect and random-effects analyses, under the assumption that
asymmetry suggests that neither model is appropriate. When the same
outcome is presented as dichotomous data in some studies and as con-
tinuous data in other studies, we will convert odds ratios (ORs) for the
dichotomous data to standardised mean differences (SMDs) if it can be
assumed that the underlying continuous measurements follow a normal
or logistic distribution. Otherwise, we will conduct separate analyses
Multiple time points
For studies in which outcomes are measured at different time points,
we will calculate the combined effect size across different time points
(Borenstein 2009)
Subgroup analysis and investigation of heterogeneity If sufficient homogenous studies are identified, we will conduct subgroup
analyses to assess the impact of the cause of speech sound disorders (e.
g. structural anomalies, neuromuscular impairment, unknown origin),
intensity of therapy (to be determinedby the frequency of therapy sessions)
, presence or absence of intellectual disability and use of NSOMTs as an
adjunct to speech intervention
Sensitivity analysis We will examine the impact of study quality on the robustness of con-
clusions by performing sensitivity analyses. Factors that are considered as
important in judging study quality include randomisation, blinding to
outcome assessment and attrition (Juni 2001). We will include studies
that we categorised as having low or unclear risk of bias for these factors
in the analysis
Evaluation of outcomes using the GRADE system We will summarise the outcomes of included studies in a ’Summary of
findings table’. We will grade each outcome using the Grading of Recom-
mendations Assessment, Development and Evaluation (GRADE) system
(Guyatt 2008). The GRADE system classifies the quality of evidence in 1
of 4 categories: (1) high quality, when further research is very unlikely to
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Table 1. Methods planned in the protocol but not used in this review (Continued)
change our confidence in the estimate of treatment effect; (2) moderate
quality, when further research is likely to have an important impact on
our confidence in the estimate of treatment effect and may change the
estimate; (3) low quality, when further research is very likely to have an
important impact on our confidence in the estimate of treatment effect
and is likely to change the estimate; and (4) very low quality, when the
estimate of treatment effect is very uncertain (Guyatt 2008). We will con-
sider the following factors when grading the quality of evidence: research
methodology, consistency of results, directness of evidence, precision of
effect estimates and whether reporting bias is likely (Guyatt 2008).
A P P E N D I C E S
Appendix 1. Search strategies
Cochrane Central Register of Controlled Trials (CENTRAL), 2014 Issue 3, part of The Cochrane Library. Last searched 15
April 2014
#1MeSH descriptor: [Speech] this term only
#2MeSH descriptor: [Speech Intelligibility] this term only
#3MeSH descriptor: [Speech Disorders] explode all trees
#4MeSH descriptor: [Apraxias] this term only
#5(speech near/3 apraxia*)
#6dysarthri*
#7(mute or mutism)
#8((speech or speak* or articulat* or phonetic* or phonologic* or phonemic*) near/5 (difficult* or disorder* or delay* or dysfunction*
or impair* or problem*))
#9speech next sound
#10#1 or #2 or #3 or #4 or #5 or#6 or #7 or #8 or #9
#11MeSH descriptor: [Speech Disorders] explode all trees and with qualifiers:[Rehabilitation - RH, Therapy - TH]
#12non next speech or nonspeech
#13MeSH descriptor: [Speech Therapy] this term only
#14MeSH descriptor: [Myofunctional Therapy] this term only
#15(myofunctional next (therap* or treat*))
#16(orofacial or oro next facial or oral next facial or oralfacial)
#17((oral or face or facial or jaw or larynx or lips or mouth or palate or tongue) near/5 (action* or exercise* or motion* or movement*
or physio* or stimulat* or stimulus or stretch* or treatment* or therapy))
#18(NSOM* or OME or OMEs)
#19(oral next motor or oromotor or oro next motor)
#20#11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19
#21#10 and #20
Ovid MEDLINE (R), 1946 to April Week 1 2014. Last searched 15 April 2014
1 Speech/
2 exp Speech Disorders/
3 Speech intelligibility/
4 Apraxias/
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5 (speech adj3 apraxia$).tw.
6 dysarthri$.tw.
7 (mute or mutism).tw.
8 ((speech or speak$ or articulat$ or phonetic$ or phonologic$ or phonemic$) adj5 (difficult$ or disorder$ or delay$ or dysfunction$
or impair$ or problem$)).tw.
9 speech sound.tw.
10 or/1-9
11 oral motor.tw.
12 oromotor.tw.
13 oro-motor.tw.
14 (NSOM$ or OME or OMEs).tw.
15 Speech Disorders/rh, th [Rehabilitation, Therapy]
16 (non-speech or nonspeech$).tw.
17 Speech Therapy/
18 Myofunctional Therapy/
19 (myofunctional adj (therap$ or treatment$)).tw.
20 (orofacial or oro-facial or oral facial or oralfacial).tw.
21 ((oral or face or facial or jaw or larynx or lips or mouth or palate or tongue) adj5 (action$ or exercise$ or motion or movement$ or
physio$ or sensory or stimulat$ or stimulus or stretching or treatment$ or therapy)).tw.
22 or/11-21
23 randomized controlled trial.pt.
24 controlled clinical trial.pt.
25 randomi#ed.ab.
26 placebo$.ab.
27 drug therapy.fs.
28 randomly.ab.
29 trial.ab.
30 groups.ab.
31 or/23-30
32 exp animals/ not humans.sh.
33 31 not 32
34 10 and 22 and 33
Ovid MEDLINE (R) In-Process & Other Non-index Citations, updated 14 April 2014. Last searched 15 April 2014
1 ((speech or speak$ or articulat$ or phonetic$ or phonologic$ or phonemic$) adj5 (difficult$ or disorder$ or delay$ or dysfunction$
or impair$ or problem$)).tw.
2 (speech adj3 apraxia$).tw.
3 dysarthri$.tw.
4 (mute or mutism).tw.
5 speech sound.tw.
6 1 or 2 or 3 or 4 or 5
7 ((oral or face or facial or jaw or larynx or lips or mouth or palate or tongue) adj5 (action$ or exercise$ or motion$ or movement$ or
physio$ or stimulat$ or stimulus or stretch$ or treatment$ or therapy)).tw.
8 oral motor.tw.
9 oromotor.tw.
10 oro-motor.tw.
11 (NSOM$ or OME or OMEs).tw.
12 (myofunctional adj (therap$ or treatment$)).tw.
13 (orofacial or oro-facial or oral facial or oralfacial).tw.
14 (speech adj3 (therap$ or rehabilit$)).tw.
15 or/7-14
16 6 and 15
EMBASE (Ovid), 1980 to 2014 Week 15. Last searched 16 April 2014
1 exp speech/
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2 exp Speech Disorder/
3 speech intelligibility/
4 apraxia/
5 (speech adj3 apraxia$).tw.
6 dysarthria/
7 dysarthri$.tw.
8 mutism/
9 (mute or mutism).tw.
10 ((speech or speak$ or articulat$ or phonetic$ or phonologic$ or phonemic$) adj5 (difficult$ or disorder$ or delay$ or dysfunction$
or impair$ or problem$)).tw.
11 speech sound.tw.
12 or/1-11
13 exp speech disorder/rh, th [Rehabilitation, Therapy]
14 speech therapy/
15 speech rehabilitation/
16 muscle training/
17 (myofunctional adj (therap$ or treatment$)).tw.
18 (orofacial or oro-facial or oral facial or oralfacial).tw.
19 ((oral or face or facial or jaw or larynx or lips or mouth or palate or tongue) adj5 (action$ or exercise$ or motion$ or movement$
or physio$ or stimulat$ or stimulus or stretch$ or treatment$ or therapy)).tw.
20 oral motor.tw.
21 oromotor.tw.
22 oro-motor.tw.
23 (non-speech or nonspeech$).tw.
24 (NSOM$ or OME or OMEs).tw.
25 or/13-24
26 12 and 25
27 exp Clinical trial/
28 Randomized controlled trial/
29 Randomization/
30 Single blind procedure/
31 Double blind procedure/
32 triple blind procedure/
33 Crossover procedure/
34 Placebo/
35 Randomi#ed.tw.
36 RCT.tw.
37 (random$ adj3 (allocat$ or assign$)).tw.
38 randomly.ab.
39 groups.ab.
40 trial.ab.
41 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
42 Placebo$.tw.
43 Prospective study/
44 (crossover or cross-over).tw.
45 prospective.tw.
46 or/27-45
47 26 and 46
ERIC (ProQuest), 1966 to current. Last searched 16 April 2014
Searched for:(SU.EXACT(”Longitudinal Studies“) OR SU.EXACT(”Control Groups“) OR SU.EXACT(”Program Effectiveness“) OR
SU.EXACT(”Experimental Groups“) OR SU.EXACT(”Followup Studies“) OR SU.EXACT(”Comparative Analysis“) OR prospective
OR ”follow up“OR ((evaluat* OR compar*ORblind*)NEAR/5 (study OR studies OR research))OR ((compar* OR control*) NEAR/
5 group*) OR random* OR intervention* OR experiment* OR trial*) AND ((SU.EXACT(”Speech“) OR SU.EXACT(”Articulation
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(Speech)“) OR SU.EXACT(”Articulation Impairments“) OR ((speech NEAR/1 sound) OR (speech OR speak[*3] OR articulat[*3]
OR phonetic[*1] OR phonologic[*4] OR phonemic[*4]) NEAR/5 (difficult[*3] OR disorder[*2] OR delay[*3] OR dysfunction[*2]))
OR (dysarthri[*1]) OR (mute ORmutism) OR (speech NEAR/1 apraxi[*1])) AND (”oral motor“ OR oromotor OR ”oro motor“ OR
NSOM[*2] OR OME OR OMEs OR nonspeech OR ”non speech“ OR orofacial OR ”oro facial“ OR ”oral facial“ OR oralfacial OR
(myofunctional NEAR/1 (therap[*5] OR treat[*5])) OR ((oral OR face OR facial OR jaw OR larynx OR lips OR mouth OR palate
OR tongue) NEAR/5 (action[*1] OR exercise[*1] OR motion[*1] OR movement[*1] OR physio[*7] OR stimulat[*3] OR stimulus
OR stretch[*3] OR treatment[*1] OR therapy)) OR SU.EXACT.EXPLODE(”Speech Therapy“) OR SU.EXACT.EXPLODE(”Speech
Improvement“)))
PsycINFO (Ovid), 1806 to April Week 2 2014. Last searched 16 April 2014
1 speech/
2 exp speech characteristics/
3 exp speech disorders/
4 apraxia/
5 (speech adj3 apraxia$).tw.
6 dysarthri$.tw.
7 Mutism/
8 (mute or mutism).tw.
9 ((speech or speak$ or articulat$ or phonetic$ or phonologic$ or phonemic$) adj5 (difficult$ or disorder$ or delay$ or dysfunction$
or impair$ or problem$)).tw.
10 speech sound.tw.
11 or/1-10
12 speech therapy/
13 rehabilitation/
14 oral motor.tw.
15 oromotor.tw.
16 oro-motor.tw.
17 (NSOM$ or OME or OMEs).tw.
18 (non-speech or nonspeech$).tw.
19 (myofunctional adj (therap$ or treatment$)).tw.
20 (orofacial or oro-facial or oral facial or oralfacial).tw.
21 ((oral or face or facial or jaw or larynx or lips or mouth or palate or tongue) adj5 (action$ or exercise$ or motion$ or movement$
or physio$ or stimulat$ or stimulus or stretch$ or treatment$ or therapy)).tw.
22 or/12-21
23 11 and 22
24 clinical trials/
25 (randomis$ or randomiz$).tw.
26 (random$ adj3 (allocat$ or assign$)).tw.
27 ((clinic$ or control$) adj trial$).tw.
28 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
29 (crossover$ or ”cross over$“).tw.
30 random sampling/
31 Experiment Controls/
32 Placebo/
33 placebo$.tw.
34 exp program evaluation/
35 treatment effectiveness evaluation/
36 ((effectiveness or evaluat$) adj3 (stud$ or research$)).tw.
37 or/24-36
38 23 and 37
CINAHL (EBSCOhost), 1939 to current. Last searched 16 April 2014
S38 S22 and S37
S37 S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30 or S31 or S32 or S33 or S34 or S35 or S36
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S36 TI (evaluat* study or evaluat* research) or AB (evaluate* study or evaluat* research) or TI (effectiv* study or effectiv* research)
or AB (effectiv* study or effectiv* research) OR TI (prospectiv* study or prospectiv* research) or AB (prospectiv* study or prospectiv*
research) or TI (follow-up study or follow-up research) or AB (follow-up study or follow-up research)
S35 placebo*
S34 crossover* or ”cross over*“
S33 (MH ”Crossover Design“)
S32 (tripl* N3 mask*) or (tripl* N3 blind*)
S31 (trebl* N3 mask*) or (trebl* N3 blind*)
S30 (doubl* N3 mask*) or (doubl* N3 blind*)
S29 (singl* N3 mask*) or (singl* N3 blind*)
S28 (clinic* N3 trial*) or (control* N3 trial*)
S27 (random* N3 allocat* ) or (random* N3 assign*)
S26 randomis* or randomiz*
S25 (MH ”Meta Analysis“)
S24 (MH ”Clinical Trials+“)
S23 MH random assignment
S22 S10 and S21
S21 S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20
S20 ((oral or face or facial or jaw or larynx or lips or mouth or palate or tongue) N5 (action* or exercise* or motion* or movement* or
physio* or stimulat* or stimulus or stretch* or treatment* or therapy))
S19 orofacial OR oro-facial or (oro facial) OR (oral facial)
S18 (myofunctional N1 (therap* or treatment*))
S17 (MH ”Speech Therapy“)
S16 (MH ”Speech Disorders/RH/TH“)
S15 non-speech* or nonspeech* or (non speech)
S14 NSOM* or OME or OMEs
S13 oro-motor or (oro motor)
S12 oromotor
S11 oral motor
S10 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9
S9 (speech sound)
S8 ((speech or speak* or articulat* or phonetic* or phonologic* or phonemic*) N5 (difficult* or disorder* or delay* or dysfunction* or
impair* or problem*))
S7 mute or mutism
S6 dysarthri*
S5 (speech N3 apraxia*)
S4 (MH ”Apraxia“)
S3 (MH ”Speech Intelligibility“)
S2 (MH ”Speech Disorders+“)
S1 (MH ”Speech“)
Science Citation Index-Expanded (SCI-EXPANDED) and Social Sciences Citation Index (SSCI) (Web of Knowledge), 1970 to
16 April 2014. Last searched 16 April 2014
Conference Proceedings Citation Index-Science (CPCI-S) and Conference Proceedings Citation Index-Social Sciences & Hu-
manities (CPCI-SSH) (Web of Knowledge), 1990 to 11 April 2014. Last searched 16 April 2014
#16#15 AND #14
DocType=All document types; Language=All languages;
#15TS=(random* or control* or trial* or groups* or effectiv* or
intervention* or evaluation or placebo*)
DocType=All document types; Language=All languages;
#14#13 AND #7
DocType=All document types; Language=All languages;
#13#12 OR #11 OR #10 OR #9 OR #8
DocType=All document types; Language=All languages;
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#12TS=(NSOM* or OME or OMEs)
DocType=All document types; Language=All languages;
#11Ts=(”oral motor“ OR oromotor OR ”oro-motor“)
DocType=All document types; Language=All languages;
#10TS=(orofacial or ”oro-facial“ or ”oral facial“ or oralfacial)
DocType=All document types; Language=All languages;
#9TS=( myofunctional NEAR/1 (therap* or treatment*))
DocType=All document types; Language=All languages;
#8TS=((oral or face or facial or jaw or larynx or lips or mouth or
palate or tongue) NEAR/5 (action* or exercise* or motion* or
movement* or physio* or stimulat* or stimulus or stretch* or
treatment* or therapy))
DocType=All document types; Language=All languages;
#7#6 OR #5 OR #4 OR #3 OR #2 OR #1
DocType=All document types; Language=All languages;
#6TS=(mute or mutism)
DocType=All document types; Language=All languages;
#5TS=(dysarthri*)
DocType=All document types; Language=All languages;
#4TS=(dysarthri*)
DocType=All document types; Language=All languages;
#3TS=(speech NEAR/3 apraxi*)
DocType=All document types; Language=All languages;
#2TS=(”speech sound“)
DocType=All document types; Language=All languages;
#1TS=((speech or speak* or articulat* or phonetic* or phonologic* or
phonemic*) NEAR/5 (difficult* or disorder* or delay* or dysfunction*
or impair* or problem*))
DocType=All document types; Language=All languages;
LILACS, http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/, all available years. Last searched 16 April 2014
(Mh SPEECH DISORDERS or Mh APRAXIAS or Mh SPEECH INTELLIGIBILITY or ( SPEECH or SPEAK OR ARTICULAT$
OR APRAXIA OR DYSARTHI$ or PHONETIC$ or PHONEMIC$ or PHONOLOGIC$)) [Words] and (Mh Myofunctional
Therapy OR Mh Speech therapy OR OROFACIAL or ”ORO FACIAL“ OR ”ORAL FACIAL“ OR orofacial OR ”oral motor“ OR
oromotor or ”oro motor“ or NSOME$ or ome OR omes ) [Words] and ((Pt randomized controlled trial OR Pt controlled clinical trial
OR Mh randomized controlled trials OR Mh random allocation OR Mh double-blind method OR Mh single-blind method) AND
NOT (Ct animal AND NOT (Ct human and Ct animal)) OR (Pt clinical trial OR Ex E05.318.760.535$ OR (Tw clin$ AND (Tw
trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw investiga$)) OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw
doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$))
OR Mh placebos OR Tw placebo$ OR (Tw random$ OR Tw randon$ OR Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$)
ORMh research design) ANDNOT (Ct animal ANDNOT (Ct human and Ct animal)) OR (Ct comparative study OR Ex E05.337$
ORMh follow-up studies ORMh prospective studies OR Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) AND
NOT (Ct animal AND NOT (Ct human and Ct animal))) [Words]
Academic Search Complete (EBSCOhost), all available years. Last searched 14 April 2014
S37 S21 and S36
S36 S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35
S35 TI (evaluat* study or evaluat* research) or AB (evaluate* study or evaluat* research) or TI (effectiv* study or effectiv* research)
or AB (effectiv* study or effectiv* research) OR TI (prospectiv* study or prospectiv* research) or AB (prospectiv* study or prospectiv*
research) or TI (follow-up study or follow-up research) or AB (follow-up study or follow-up research)
S34 placebo*
S33 crossover* or ”cross over*“
S32 Crossover Design
S31 (tripl* N3 mask*) or (tripl* N3 blind*)
S30 (trebl* N3 mask*) or (trebl* N3 blind*)
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S29 (doubl* N3 mask*) or (doubl* N3 blind*)
S28 (singl* N3 mask*) or (singl* N3 blind*)
S27 (clinic* N3 trial*) or (control* N3 trial*)
S26 (random* N3 allocat* ) or (random* N3 assign*)
S25 randomis* or randomiz*
S24 SU Meta Analysis
S23 SU Clinical Trials
S22 random assignment
S21 S10 AND S20
S20 S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19
S19 ((oral or face or facial or jaw or larynx or lips or mouth or palate or tongue) N5 (action* or exercise* or motion* or movement* or
physio* or stimulat* or stimulus or stretch* or treatment* or therapy))
S18 orofacial or oro-facial or (oro facial) or (oral facial)
S17 myofunctional N1 (therap* or treatment*)
S16 SU Speech Therapy
S15 non-speech* or nonspeech* or (non speech)
S14 NSOM* or OME or OMEs
S13 oro-motor or (oro motor)
S12 oromotor
S11 oral motor
S10 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9
S9 (speech sound)
S8 ((speech or speak* or articulat* or phonetic* or phonologic* or phonemic*) N5 (difficult* or disorder* or delay* or dysfunction* or
impair* or problem*))
S7 mute or mutism
S6 dysarthri*
S5 (speech N3 apraxia*)
S4 SU Apraxia
S3 SU Speech Intelligibility
S2 SU Speech Disorders
S1 SU Speech
ProQuest Dissertations and Theses: UK & Ireland, 1990 to current. Last searched 14 April 2014
Searched for:(SU.EXACT(”Longitudinal Studies“) OR SU.EXACT(”Control Groups“) OR SU.EXACT(”Program Effectiveness“) OR
SU.EXACT(”Experimental Groups“) OR SU.EXACT(”Followup Studies“) OR SU.EXACT(”Comparative Analysis“) OR prospective
OR ”follow up“OR ((evaluat* OR compar*ORblind*)NEAR/5 (study OR studies OR research))OR ((compar* OR control*) NEAR/
5 group*) OR random* OR intervention* OR experiment* OR trial*) AND ((SU.EXACT(”Speech“) OR SU.EXACT(”Articulation
(Speech)“) OR SU.EXACT(”Articulation Impairments“) OR ((speech NEAR/1 sound) OR (speech OR speak[*3] OR articulat[*3]
OR phonetic[*1] OR phonologic[*4] OR phonemic[*4]) NEAR/5 (difficult[*3] OR disorder[*2] OR delay[*3] OR dysfunction[*2]))
OR (dysarthri[*1]) OR (mute ORmutism) OR (speech NEAR/1 apraxi[*1])) AND (”oral motor“ OR oromotor OR ”oro motor“ OR
NSOM[*2] OR OME OR OMEs OR nonspeech OR ”non speech“ OR orofacial OR ”oro facial“ OR ”oral facial“ OR oralfacial OR
(myofunctional NEAR/1 (therap[*5] OR treat[*5])) OR ((oral OR face OR facial OR jaw OR larynx OR lips OR mouth OR palate
OR tongue) NEAR/5 (action[*1] OR exercise[*1] OR motion[*1] OR movement[*1] OR physio[*7] OR stimulat[*3] OR stimulus
OR stretch[*3] OR treatment[*1] OR therapy)) OR SU.EXACT.EXPLODE(”Speech Therapy“) OR SU.EXACT.EXPLODE(”Speech
Improvement“)))
ProQuest Dissertations and Theses A&I, 1970 to current. Last searched 14 April 2014
((”oral motor“ OR oromotor OR ”oro motor“ OR ”NSOM[*2]“ OROMEOROMEs OR orofacial OR ”oro facial“ OR ”oral facial“
OR oralfacial ORmyofunctional) NEAR/5 (action* OR exercise* ORmotion* ORmovement*OR physio*OR stimulat* OR stimulus
OR stretch* OR treatment* OR therap* OR intervention)) AND (speech OR speak* OR articulat* OR phonetic* OR phonologic*
OR phonemic*) AND child*
Cochrane Database of Systematic Reviews (CDSR), 2014 Issue 4 of 12. Last searched 15 April 2014
#1MeSH descriptor: [Speech] this term only
#2MeSH descriptor: [Speech Intelligibility] this term only
#3MeSH descriptor: [Speech Disorders] explode all trees
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#4MeSH descriptor: [Apraxias] this term only
#5(speech near/3 apraxia*)
#6dysarthri*
#7(mute or mutism)
#8((speech or speak* or articulat* or phonetic* or phonologic* or phonemic*) near/5 (difficult* or disorder* or delay* or dysfunction*
or impair* or problem*))
#9speech next sound
#10#1 or #2 or #3 or #4 or #5 or#6 or #7 or #8 or #9
#11MeSH descriptor: [Speech Disorders] explode all trees and with qualifiers: [Rehabilitation - RH, Therapy - TH]
#12non next speech or nonspeech
#13MeSH descriptor: [Speech Therapy] this term only
#14MeSH descriptor: [Myofunctional Therapy] this term only
#15(myofunctional next (therap* or treat*))
#16(orofacial or oro next facial or oral next facial or oralfacial)
#17((oral or face or facial or jaw or larynx or lips or mouth or palate or tongue) near/5 (action* or exercise* or motion* or movement*
or physio* or stimulat* or stimulus or stretch* or treatment* or therapy))
#18(NSOM* or OME or OMEs)
#19(oral next motor or oromotor or oro next motor)
#20#11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19
#21#10 and #20
Database of Abtracts of Reviews of Effects (DARE), 2014 Issue 1 of 4. Last searched 15 April 2014
#1MeSH descriptor: [Speech] this term only
#2MeSH descriptor: [Speech Intelligibility] this term only
#3MeSH descriptor: [Speech Disorders] explode all trees
#4MeSH descriptor: [Apraxias] this term only
#5(speech near/3 apraxia*)
#6dysarthri*
#7(mute or mutism)
#8((speech or speak* or articulat* or phonetic* or phonologic* or phonemic*) near/5 (difficult* or disorder* or delay* or dysfunction*
or impair* or problem*))
#9speech next sound
#10#1 or #2 or #3 or #4 or #5 or#6 or #7 or #8 or #9
#11MeSH descriptor: [Speech Disorders] explode all trees and with qualifiers: [Rehabilitation - RH, Therapy - TH]
#12non next speech or nonspeech
#13MeSH descriptor: [Speech Therapy] this term only
#14MeSH descriptor: [Myofunctional Therapy] this term only
#15(myofunctional next (therap* or treat*))
#16(orofacial or oro next facial or oral next facial or oralfacial)
#17((oral or face or facial or jaw or larynx or lips or mouth or palate or tongue) near/5 (action* or exercise* or motion* or movement*
or physio* or stimulat* or stimulus or stretch* or treatment* or therapy))
#18(NSOM* or OME or OMEs)
#19(oral next motor or oromotor or oro next motor)
#20#11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19
#21#10 and #20
speechBITE, www.speechbite.com/, all available years. Last searched 17 April 2014
”speech sound“ filtered by publication type= RCTs
The National Research Register (NRR) Archive, www.nihr.ac.uk/Pages/NRRArchiveSearch.aspx. Last searched 6 February 2013,
as archive was last modified in October 2010
speech OR articulation in All Fields
Search results for “non speech” OR “oral motor” OR nsom* in methodology
UK Clinical Research Network Portal (UKCRN), http://public.ukcrn.org.uk/search/. Last searched 17 April 2014
Topics: all
Research summary: speech articulation
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Searching with ”Any“ term selected
ClinicalTrials.gov, http://clinicaltrials. gov/. Last searched 16 April 2014
Advanced Search
speech sound OR articulation | Child
metaRegister of Current Controlled Trials (mRCT), www.controlled-trials.com/mrct/. Last searched 17 April 2014. This service
is currently under review (19 December 2014)
non motor OR nonmotor OR NSOME*
World Health Organization International Clinical Trials Registry Platform (ICTRP), http://apps.who.int/trialsearch/. Last
searched 17 April 2014
non speech OR NSOME* OR oral motor OR oromotor
C O N T R I B U T I O N S O F A U T H O R S
AL and FG planned the review. AL was the primary author of the protocol. AL developed and conducted the search strategies with
help from Ms Margaret Anderson. AL and FG independently assessed titles. AL is the primary author of the review.
D E C L A R A T I O N S O F I N T E R E S T
Alice S-Y Lee: none known.
Fiona E Gibbon: receives royalties as Co-Editor of The Handbook of Clinical Phonetics. The Japan Cleft Palate Association paid travel
and accommodation costs for Professor Gibbon to give a keynote lecture in May 2012. Professor Gibbon is principal investigator on
the project titled ”The effect of speaker accent on sentence comprehension in children with language delay“. The Health Research
Board is paying funds to the University College Cork for this project from 2012 to 2015. Professor Gibbon was paid honorarium in
2013 for advice on research strategy for the Research Assessment Exercise at the University of Hong Kong.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied, Other.
External sources
• No sources of support supplied, Other.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Parts of the Background section have been rewritten. It now contains an updated and detailed definition of developmental speech
sound disorders and additional information regarding the debate on efficacy of non-speech oral motor treatments (NSOMTs).
As recommended by the Trials Search Co-ordinator for the Cochrane Developmental, Psychological and Learing Problems Group,
we searched five additional electronic databases that were not listed in the protocol: (1) Ovid MEDLINE In-Process & Other Non-
index Citations; (2) Cochrane Database of Systematic Reviews (CDSR); (3) Database of Abstracts of Reviews of Effects (DARE); (4)
Conference Proceedings Citation Index-Science (CPCI-S) and Conference Proceedings Citation Index-Social Sciences & Humanities
(CPCI-SSH); and (5) speechBITE (http://www.speechbite.com/).
We had hoped to assess the quality of all primary outcomes using the Grading of Recommendations Assessment, Development and
Evaluation (GRADE) system (Guyatt 2008) and to report these ratings in a ’Summary of findings table’, but we did not, as the studies
were too heterogeneous to be combined in a meta-analysis. We have added this intention to our additional methods, which have been
archived for future updates of this review (see Table 1).
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